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General abstract 
The aim of this PhD project was the valorization of by-products from some mediterranean 
plant foods through their re-utilization in new functional foods and ingredients having the 
ability to modulate the oxidative processes and nutrient metabolism in the gastrointestinal 
tract (GiT).  
Obesity is an urgent social problem and functional foods able to modulate oxidative stress and 
energy homeostasis are promising tools to control inflammatory status and body weight.  
Several evidence shows that polyphenols (PPs) and dietary fiber (DF) may control energy 
intake and appetite in humans through several mechanisms. PPs may quench free radicals 
forming in GiT, may counteract subclinical oxidative stress and high-fat diet induced 
inflammation, and may also influence the activity of key digestive enzymes thus modulating 
nutrients bioavailability and the related neuro-hormonal signals. In this way, PPs are 
hypothesized able to modulate appetite cues in the short term, and to control body weight in 
the long term. However, food processes as well as the physicochemical interconnections of 
PPs with DF and other food components are crucial factors influencing their bioaccessibility 
and their functionality along the GiT. 
Plant foods by-products from agricultural and food industry are a natural and cheap source of 
PPs and DF. In this thesis the possible reutilization of pomegranate peels (PPe), artichoke 
leaves (ALe) and stems (AS), and olive leaves (OLe) was investigated by developing three 
studies. 
In a first study the bioaccessibility of PPs from PPe and a PPe-enriched cookie (PPeC), their 
potential total antioxidant capacity (TAC) along the GiT, as well as the ability of PPeC to 
modulate glucose and lipid metabolism was assessed. To this purpose PPeC were developed 
and in vitro sequential enzyme digestion coupled to LC/MS/MS and biochemical analyses of 
the soluble and insoluble fractions collected at each digestion steps were carried out. Data 
showed the chemical transformations induced by baking process on PPe PPs, the potential 
release of antioxidants along the GiT and their ability to inhibit α-glucosidase, α-amylase and 
lipase activities in the duodenal tract. 
In a second study the development of breads enriched with AS at 3%, 6% and 9% was 
performed and the intestinal fate of PPs and cynaropicrin was studied in vitro using a 
simulated human digestion model coupled to High Resolution Mass Spectrometry (HRMS) 
analysis of digestive extracts. The potential metabolic fate of PPs and cynaropicrin from AS-
  
enriched breads  and the ability of the extracts from the duodenal step to inhibit α-glucosidase 
activity was assessed.  
A third study was conducted in collaboration with Prof. Bruce Hamaker and Prof. Osvaldo 
Campanella at Purdue University, (Indiana, USA) and consisted in the development of new 
antioxidant DF by including PPs-rich extracts from PPe, OLe and ALe in starch-alginate 
based microspheres (MS). The physicochemical properties of the new ingredients were 
compared to those of 6 commercially available DF concentrates as well as to whole wheat 
bran and oat bran in order to position the new ingredients on the actual market of DF 
concentrates and dietary source of DF. 
All in all data obtained in this thesis demonstrated that plant foods by-products are promising 
source of PPs and DF to develop foods and ingredients that may control oxidation and 
nutrient metabolism along the GiT. 
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1.1 An overview on an urgent social problem: The spread of overweight and obesity 
In 2014, the World Health Organization (WHO) estimated that more than 1.9 billion of adults 
were overweight. Of these over 600 million were obese. The tremendous increase of overweight 
and obesity worldwide is associated to an increase within the population of non communicable 
chronic diseases (NCCDs)¸ mainly including cardiovascular diseases, type 2 diabete, 
hypertension and some types of cancer.1 Consequently, the rising prevalence of overweight and 
obesity is associated to social and financial burdens, such as higher health-care costs for diseases 
treatment as well as increased loss of work.2 
The primary cause of overweight and obesity is the imbalance between energy intake and energy 
expenditure. Several factors may co-work to innescate this condition such as early life factors, 
individual predisposition (genetic and epigenetic characters), social factors, lifestyle as well as 
food nutritional properties.3,4 
To manage this global social challenge, from many years international and national authorities 
started campaigns for the promotion of physical activity and of guidelines for a healthy diet. A 
healthy diet should include 400 g/day of fruits and vegetables, legumes, nuts and wholegrains, 
less than 10% of daily energy intake from free sugars, less than 30% of daily energy intake from 
fats, reducing saturated fats to less than 10% of total energy intake and trans fats to less than 1% 
of total energy intake, and replacing both with unsaturated fats, and less than 5 g/day of salt.5 
In this context the food industry may play a crucial role. It should increase the efforts to market 
food products with a composition in line with the international nutritional guidelines, and should 
promote the research and the development of new functional foods that, beyond their nutritional 
role, are able to prevent metabolic syndrome by modulating physiological processes underlying 
the control of appetite and body weight gain.6-8 
It is well know that on the basis of their specific chemical composition (types and amount of 
macronutrients, micronutrients and non-nutrients bioactive compounds) as well as their physical 
and sensory properties, foods can affect cognitive, hedonic, neuroendocrine and homeostatic 
factors underlying the regulation of appetite and of energy intake. For example, solid foods are 
more satiating than liquid foods and among macronutrients proteins are recognised as more 
satiating than carbohydrates and fats.9,10 Additionally, some non-nutritional bioactive food 
components, mainly including dietary fiber (DF) and polyphenols (PPs), may act as modulators 
of physiological signals involved in the regulation of energy intake.11,12 
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small intestine thus influencing post-prandial blood glucose and the related hormonal response, 
with effects on fats oxidation and satiety.39,40  
Similarly, pancreatic lipase is the enzyme responsible of hydrolysis of dietary fats, mainly 
triglycerides (90–95%). The hydrolysis of fats starts in the mouth, then continues in the stomach 
by gastric lipase, and in the duodenum through the synergistic actions of gastric and pancreatic 
lipases, leading to the formation of monoglycerides and free fatty acids. These compounds are 
absorbed by the enterocytes to synthesize new triglyceride molecules, which are transported to 
the different organs via lipoproteins, especially chylomicrons. The inhibition of pancreatic lipase 
lows digestion of triglycerides, resulting in a lower absorption of fatty acids and a reduced 
energy intake.34  
Some classes of PPs and other plant-derived bioactive compounds, mainly including 
secoiridoids, iridoids and other terpenoids, can bind specific bitter receptors located along the 
GiT, which can elicit the secretion of hunger and satiety hormones regulating gastrointestinal 
motility and response to food as well as appetite.41-47 Recent evidence shows that PPs reaching 
the low GiT, i.e. the polymerized PPs or those covalently bound to DF, may counteract intestinal 
and systemic inflammation correlated to metabolic syndrome and obesity by influencing the 
abundance of microbial species towards a healthy profile.28,48-54 So, DF can be considered as a 
functional carrier of bioactive PPs along the GiT.16 
DF were defined as “carbohydrate polymers with ten or more monomeric units which are not 
hydrolysed by the human enzymes in the small intestine and belong to the following categories:” 
1) Edible carbohydrate polymers naturally occurring in the food as consumed; 2) Carbohydrate 
polymers, which have been obtained from food raw material by physiological, enzymatic or 
chemical means and which have been shown to exert physiological benefits as demonstrated by 
generally accepted scientific evidence to competent authorities; 3) Synthetic carbohydrate 
polymers with a demonstrated beneficial physiological effect on health.55,56 
On the basis of the water solubility, DF can be divided into soluble DF and insoluble DF, mainly 
including cellulose, hemicelluloses, and lignin. According to the water-solubility and other 
physicochemical properties, DF may influence the physiological processes underlying food 
intake and weight gain through different mechanisms (see Figure 1.3.).17,57-59 
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YY, respectively. Moreover, the activation of these SCFA-activated G-coupled protein receptors 
was associated with an increased secretion of glucagon-like peptide 1 (GLP-1) and glucose-
dependent insulinotropic peptide (GIP).66,67 
Table 1.1. Physicochemical properties of DF affecting technological properties of food and physiological processes. 
Adapted by Elleuch et al., (2011).62 
Physicochemical 
properties of DF 
Technological properties in foods Potential physiological implications 
High water holding 
capacity 
Avoids syneresis and affects viscosity and 
texture of foods 
Increases the fecal bulk volume and the 
mastication time; Laxative effects 
High oil holding 
capacity 
Stabilizes emulsions in high-fat foods 
 
Effects on fat digestion and absorption in 
the GiT  
High water-
solubility/viscosity 
Influences the food texture potentially 
forming gels and acting as emulsifier 
Affects bioacessibility, bioavailability and 
metabolic fate of carbohydrates and lipids 
Antioxidant activity 
Improves the oxidative stability of foods 
and prolongs the shelf life 
Influences the colonic microbiota 
composition  
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1.3 Vegetable by-products as sustainable source of non-nutritional bioactive 
compounds 
Food wastes are defined as “Wholesome edible material intended for human consumption, 
arising at any point in the food supply chain, that is instead discarded, lost, degraded or 
consumed by pests as well as the edible material that is intentionally fed to animals or that is a 
by-product of food processing diverted away from the human food ”.68 
In line with the European legislation, the waste products resulting from a production process, 
may be considered as by-products, only according to certain conditions: 1) The use of the 
products is certain; 2) The products can be used directly without any further processing other 
than normal industrial practice; 3) The product is produced as an integral part of a production 
process; 4) Its use is lawful and will not lead to overall adverse environmental or human health 
impacts.69 The industrial processing of fruits and vegetables for the production of oils, juices, 
jams or canned foodstuffs has as a consequence the production of large amounts of food 
processing by-products, mainly including peels, leaves, stems, pomace, processing waters and 
seeds. The large disposal of this materials results in high costs for the food industry and can have 
a negative environnmental impact.70,71 
The estimated percentage of food wastes and by-products ranges from 30% to 50% for fruit and 
vegetable juices production, from 5% to 30% for fruit and vegetable processing and preservation 
and from 40% to 70% for vegetable oils production.72 
It is worth to notice that fruits from the temperate areas, as the mediterranean region, are usually 
characterized by a moderate amounts of waste material whereas considerably higher ratios of by-
products arise from tropical and subtropical fruits processing.73 
Globe artichoke (Cynara cardunculus L. var. scolymus) and olive (Olea europea L.) are two 
vegetable products distributed worldwide and mainly cultivated in the Mediterranean region. 
Italy is the first world producer of globe artichoke (451461 tons/year) followed by Egypt 
(266196 tons/year) and Spain (234091 tons/year).74 The immature inflorescence, also termed 
capitula or head, represents the edible part of globe artichoke and is consumed worldwide as a 
fresh, frozen, or canned foodstuff.75 Conversely, artichoke by-products from industrial 
processing, mainly including stems and external leaves account for about 80-85 % of the total 
fresh weight of the plant.76 Concerning the world production of olives, Spain is the first world 
producer (4560400 tons/year) followed by Italy (1963676 tons/year) and Grece (1780560 
tons/year).74 Olives are mainly cultivated for the extraction of extra virgin olive oil, that 
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represents the major final product of industrial olives processing. Olive leaves mainly result from 
the pruning of olive trees as well as from the harvesting and cleaning of olives prior to oil 
extraction. Specifically, the production of olive leaves from pruning has been estimated to be 
25 kg per olive tree.77 However, an additional amount of leaves equal to 10% of the total weight 
of the harvested olives, is collected at the oil mill step.78  
In the last decade, due to the recognized health benefits associated to the juice consumption, the 
cultivation of pomegranate trees (Punica Granatum L.), beyond in the Mediterranean countries 
where they has been cultivated extensively from long time (Tunisia, Turkey, Egypt, Spain, and 
Morocco), it increased in Italy, mainly including in the Southeastern regions.79-82 The 
pomegranate fruits are majorly processed by the food industry to obtain the juice from the arils, 
while PPe, representing about 50% of the fresh fruit weight, are discarded and are commercially 
available as a dietary supplement.83 
Considering the huge amounts of these processing products as well as the estimated percentage 
of by-products resulting by the industrial processing, their disposal represents a serious problem 
for the respective industries.  
In recent decades, the growing demand by consumers of functional foods enriched with bioactive 
compounds, as well as the increased interest of food industry for the development of more 
environmentally friendly food processes, led to the search of new sustainable solutions for the 
exploitation of by-products resulting from plant foods processing.84-86 In this frame, plant foods 
by-products are rich low-cost sources of PPs and DF and can be used for the recovery of proteins 
and colorants. However, the utilization of vegetable by-products in food applications could 
present some criticisms related to their safety of use. The individuation of potentially hazardous 
constituents inside the by-products could allow the selection of safe doses in the final food 
products.70, 73,87 Microbial issues of the by-product can be avoided submitting the material to 
washing and drying steps by oven or lyophilization. The dried products can be milled and 
submitted to a solvent extraction for the recovery of bioactive compounds, or directly used in 
their whole form as functional flours for the formulation of new DF-rich foods.71, 88, 89 Drying of 
the ingredients can be also combined with other processes on the final product (such as for 
example thermal treatments) aiming to reduce the overall microbial load. 
In Figure 1.4. the estimated total amount of DF in some plant foods by-products was reported. It 
is worthy to notice that, excluding bran from rice and oat and kiwi pomace, the total amount of 
DF in plant by-products, is always more than 40%, calculated on the basis of dry weight. 
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Despite there is a large number of studies about the inclusion of bioactive compounds from plant 
foods by-products in functional foods, there is a lack of knowledge concerning the interactions of 
these bioactive compounds with the other components of the food matrix as well as their 
potential health benefits along the GiT. 70, 90-99 
 
Figure 1.4. Amount of total dietary fiber in some plant foods by-products. Data were from Elleuch et al., 2011 62 
and Sharma et al., 2016 88 
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1.4 Functional foods and health claims 
The term functional foods was first coined in Japan in 1984 in order to define “Foods fortified with 
special constituents that possess advantageous physiological effects”.100  
In 1999, a more complex definition of functional foods was introduced by the European 
Commission’s Concerted Action on Functional Food Science in Europe (FuFoSE). In its definition 
the Commission has better clarified the concept of "functional" applied to food science. 
Specifically, according to FuFoSE “a food product can only be considered functional if together 
with the basic nutritional impact it has beneficial effects on one or more functions of the human 
organism thus either improving the general and physical conditions or/and decreasing the risk of 
the evolution of diseases. The amount of intake and form of the functional food should be as it is 
normally expected for dietary purposes. Therefore, it could not be in the form of pill or capsule just 
as normal food form”.101 More recently, the Functional Food Center/Functional Food Institute, 
located in Dallas (Texas, USA) defined functional foods as “Natural or processed foods that 
contains known or unknown biologically-active compounds; which, in defined, effective non-toxic 
amounts, provide a clinically proven and documented health benefit for the prevention, 
management, or treatment of chronic disease”. 102 
In Japan, functional foods are considered a special food category and are defined "Foods for 
Specific Health Uses (FOSHU). The Japanese Ministry of Health and Welfare is the legislative 
institution appointed to release a FOSHU designation after an evaluation process that typically 
requires one year. In the United States the Food and Drug Administration (FDA) recognizes dietary 
supplements and medical foods and is the legislative institution that, based on the strength of the 
scientific evidence, takes the final decision concerning the proposals of health claim for food 
products with beneficial effects on health.102 
In the European (EU) context, functional foods are not considered a specific category of foods, 
therefore the general EU legislation on foods can be applicable to this products depending on their 
specific nature. However, from 2006 the utilization of nutrition and health claims appearing in food 
labels is under specific EU regulations (EC regulation 1924/2006, EC regulation 353/2008, EC 
regulation 1169/2009, EC regulation 432/2012, EC regulation 1047/2012).103-107  
The EC regulation 1924/2006 defined the difference between "Nutrition claim" and "Health claim". 
Specifically, a “nutrition claim means any claim which states, suggests or implies that a food has 
particular beneficial nutritional properties due to:  
(a) the energy (calorific value) it 
 provides;  
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 provides at a reduced or increased rate; or  
 does not provide; and/or  
(b) the nutrients or other substances it  
 contains;  
 contains in reduced or increased proportions; or  
 does not contain. 
On the other hand a “health claim means any claim that states, suggests or implies that a 
relationship exists between a food category, a food or one of its constituents and health”. 
The European Commission, taking into account the independent assessments and advices supplied 
by the European Food Safety Authority (EFSA), authorizes the utilization of nutrition and health 
claims on food labelling. According to the EU functional food legislation, a list of authorised and 
not-authorised nutrition and health claims made on foods has been published in a register 
consultable online by all the EU state members.108 
The United States, Japan and Europe are considered the world's largest markets of functional foods, 
accounting for the 90% of the total world sales. Within the Europe the major markets are the United 
Kingdom, Germany, France and Italy.109 
Considering that the total costs for the development of a conventional new food product range 
between 1 and 2 million of US dollars, it can be estimated that the costs for the development and 
marketing of a functional food are higher by far. In fact, the development and marketing of 
functional foods is a multi-disciplinary and multi-steps process that requires research efforts 
finalized to the identification of the functional compounds and their inclusion on a final product that 
is sensory acceptable and effective in human body.110 Thus, researches on food processing and 
transformation as well as on validation of the efficacy through clinical trials are necessary to gain 
approval for health-enhancing marketing claims. The scale-up of the technologies, the marketing of 
the new products as well as the legislative aspects regulating the nutritional informations required 
on the label and the types of allowed nutritional and health-claims have to be taken into account for 
the estimation of total costs in the development stage and before the launch on the market of the 
final product.111  
According to Betoret et al., (2011) the technological strategies used in food processing for the 
development of new functional foods can be divided in three principal groups:112 
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 Technologies traditionally used in food processing, mainly including formulation, blending 
as well as cultivation and animal breeding techniques finalized to obtain improved food 
products; 
 Technologies designed to prevent the deterioration of physiologically active compounds, 
mainly including microencapsulation, development and utilization of edible films and 
coatings or the vacuum impregnation, the latter considered a useful way to introduce 
desirable solutes into the porous structure of foods, thus modifying their original 
composition; 
 Others more recent technologies that contribute to customize designed functional foods, 
mainly including nutrigenomics. 
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1.5 Abbreviations 
DF: Dietary fiber; 
EFSA: European Food Safety Authority 
FDA: Food and Drug Administration 
FFA: Free fatty acid; 
FOSHU: Foods for Specific Health Uses  
GIP: Glucose-dependent insulinotropic peptide. 
GiT: Gastrointestinal tract; 
GLP-1: Glucagon-like peptide 1; 
NCCDs: Non communicable chronic diseases; 
OHC: Oil holding capacity; 
PPs: Polyphenols;  
SCFA: Short-chain fatty acids; 
WHC: Water-holding capacity; 
WHO: World Health Organization; 
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Abstract 
 Obesity is an urgent social problem and new functional foods providing polyphenols and 
dietary fibers (DF) may be promising tools to modulate oxidative stress, inflammation and 
energy homeostasis. Pomegranate peels (PPe) are an agro-industrial by-product containing 
polyphenols such as ellagitannins (ETs), gallic acid (GA), ellagic acid (EA) and its derivatives 
(EAs), as well as DF. In this study, PPe enriched cookies (PPeC) were developed and the 
bioaccessibility of their polyphenols as well as the ability to exert antioxidant activity along 
the gastro-intestinal tract (GiT) and to modulate digestive enzymes was evaluated in vitro. 
Data showed that the potential bioaccessibility of ETs was 40% lower from PPeC than PPe 
whereas EAs and GA bioaccessibility increased by 93% and 52% for PPeC compared to PPe. 
The concentration of the polyphenols at each digestion step was associated with the total 
antioxidant capacity of the potentially bioaccessible material. Moreover the polyphenols 
released in the simulated duodenal phase upon PPeC digestion exhibited inhibitory activity 
towards α-glucosidase, α-amylase and lipase, being for α-glucosidase > α-amylase > lipase. In 
conclusion data demonstrated that the inclusion of PPe at 7.5% in a bakery product potentially 
leaded to a high bioaccessibility of ETs degradation products (mainly EA and EAs) in the 
duodenum, with a consequent antioxidant protection along the GiT and modulation of glucose 
metabolism. Further human studies are warranted to evaluate whether these effects also occur 
in vivo.  
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2.1 Introduction 
Obesity consists in excessive body fat accumulation resulting from an imbalance between 
individual energy intake and expenditure. In 2014, more than 1.9 billion of adults were 
overweightand over 600 million of these were obese.1 The tremendous increase of obesity 
worldwide is associated to an increase among population of non communicable chronic 
diseases (NCCD), such as cardiovascular diseases, type 2 diabetes, and some types of 
cancer.2,3 Subclinical oxidative stress and inflammation are key factors in the pathogenesis of 
obesity-related diseases.4 Healthy lifestyle, including energy balanced and variegate dietary 
regimens, together with a sufficient level of physical activity, are known to be the best 
strategies to fight overweight and associated diseases.1 However, educational campaign and 
promotion of physical activity failed among population. Thus, the consumption of foods 
providing bioactive compounds, such as polyphenols and dietary fibers (DF), may represent 
an effective strategy to prevent obesity and the risk of associated NCCD.5-8 
Jointly with DF, polyphenols are very promising ingredients for the formulation of functional 
foods aiming to target gastro-intestinal tract (GiT) and metabolic pathways underpinning 
appetite and body weight control.8-13 In fact, beside their ability to quench free radicals 
forming in the GiT, thus acting as antioxidants, polyphenols may influence the activity of 
digestive enzymes, such as α- amylase, α-glucosidase and pancreatic lipase, thus modulating 
nutrients bioavailability and the hormonal response triggered by foods.4,14-20 
The chemical structure of polyphenols, as well as their disposition in the food matrix can 
highly influence their availability to react against free radicals and to inhibit digestive 
enzymes in the GiT. Therefore, the study of bioaccessibility of polyphenols along the GiT, 
also using in vitro human digestion models, is very useful to foresee their functional effects in 
human body. 
Fruits, vegetables and whole grains are the most important dietary sources of polyphenols.21,22 
Nevertheless, by-products of plant food processing may represent a natural and cheap 
promising source of polyphenols for nutraceutical purpose.23 They can be extracted to recover 
purified biophenols or, more advantageously, they may be used as whole powder and added 
as functional ingredients in food formulation, providing also a considerable amount of DF.24,25 
In this frame, pomegranate peels (PPe) represent a very promising agro-industrial by-product, 
due to their high content of bioactive compounds such as ellagitannins (ETs), mainly 
including punicalagin, gallic acid (GA), ellagic acid (EA) and its derivatives (EAs), as well as 
DF (33-62% of PPe on dry weight).26-28 The pomegranate fruits are majorly processed by 
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food industry to obtain the juice from the arils, while PPe, representing about 50% of fresh 
fruit weight, are discarded and are commercially available as a dietary supplement.29 PPe have 
higher content of total polyphenols and higher antioxidant capacity than the pulp fraction.30 
Several evidence indicate that ETs and EA from pomegranate may be protective against many 
chronic diseases, such as some types of cancers, type 2 diabetes, atherosclerosis and 
cardiovascular diseases.31,32 Recent in vitro studies pointed out that the benefits of ETs and 
EA from pomegranate was due to their anti-inflammatory, antioxidant and digestive enzyme 
inhibitory action along the GiT.15,31,33-40 
Only few studies proposed PPe powder as functional ingredient to increase the antioxidant 
capacity, the nutritional value and the shelf-life of some foods, such as sunflower oil, wheat 
bread, cookies and meat products.41-46 A very recent in vitro study showed that a PPe flour 
could release ETs and EA during an in vitro sequential enzyme digestion, might modify 
antioxidant status and lead to the production of short-chain fatty acids inside the GiT.47 
However, a lack of knowledge still exists in the literature regarding the potential functionality 
of PPe when used as functional ingredient in baked food products. 
This study aimed at assessing the bioaccessibility of polyphenols from a PPe powder and PPe-
enriched cookies (PPeC), their potential antioxidant capacity along the GiT as well as the 
ability of PPeC to modulate glucose and lipid metabolism. To this purpose, PPeC were 
developed and in vitro sequential enzyme digestions coupled to LC/MS/MS and biochemical 
analyses of the fractions collected at each digestion steps were used to determine the chemical 
transformations induced by baking process on PPe polyphenols and to assess the step-by-step 
release of antioxidant activity as well as the overall potential antioxidant capacity of PPeC. 
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2.2 Material and methods 
2.2.1 Chemicals 
Water and methanol used for the analysis were of HPLC grade (Merck, Germany). Ethanol 
and formic acid were purchased from VWR international (Fontenay-sous-Bois, France). 
Cellulose powder was obtained from Fluka (Buchs, Switzerland). Total dietary fiber assay kit 
was purchased from Megazyme International (Wicklow, Ireland). Calcium chloride, 6-
hydroxy-2,5,7,8- tetramethylchroman-2-carboxylic acid (Trolox), 2,2-diphenyl-1-
picrylhydrazyl, 95% (DPPH), sodium bicarbonate, hydrochloric acid, acetic acid, celite, 5,5′-
dithiobis(2-nitrobenzoic acid), tris(hydroxymethyl)aminomethane hydrochloride (Tris-HCl), 
2,3-dimercapto-1-propanol tributyrate, starch Azure, 4-morpholinoethanesulfonic acid (MES), 
para-nitrophenyl-α-d glucopyranoside, sodium phosphate dibasic heptahydrate were 
purchased from Sigma-Aldrich (St. Louis, MO). Standards of punicalagin, EA and GA were 
purchased from Sigma-Aldrich (St. Louis, MO). Lipase from Aspergillus niger (187 U/g), α-
amylase from porcine pancreas (type VI-B ≥ 10 U/mg), α-glucosidase from Saccharomyces 
cerevisiae (Type I ≥ 10 U/mg), bacterial protease from Streptomyces griseus (Pronase E, Type 
XIV ≥ 3.5 U/mg), cell wall degrading enzyme complex from Aspergillus sp. (Viscozyme L), 
pancreatin from porcine pancreas (4 X USP) and pepsin from porcine gastric mucosa (≥ 250 
U/mg) were purchased from Sigma-Aldrich (St. Louis, MO). The ingredients for cookies 
preparation were purchased from a local market 
2.2.2 PPe powder dietary fiber 
A commercially available PPe powder was used in this study. It was purchased from Detrade 
UG (Bremen, Germany). The content of total dietary fiber (TDF), including soluble dietary 
fiber (SDF) and insoluble dietary fiber (IDF), was determined using the protocol described by 
Prosky et al., (1987).48 
2.2.3 PPeC preparation 
PPeC and control cookies (CTC), were prepared according to a recipe described in AACC 
(American Association of Cereal Chemists), method 10-54 (AACC, 2000) with some 
modifications.49 Particularly, dough was prepared mixing 40 g of wheat flour, 5 g of PPe, 17.5 
g of sugar, 10 g of butter, 0.8 g of NaHCO3, 0.2 g of NaCl and 18 g of water. In CTC, PPe 
powder was substituted with the same amount of inert cellulose powder. To achieve 
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maximum homogeneity between the two samples, each dough was rolled between two bars 
with a height of 3 mm and was shaped in a disk of 30 mm diameter. CTC and PPeC were 
baked simultaneously at 170°C for 12  min in a forced-air circulation oven. The final 
concentration of PPe powder in PPeC was 7.5%. 
2.2.4 In-vitro sequential enzyme digestion of PPe powder and PPeC 
The sequential enzyme digestions of PPe, PPeC and CTC were performed following the 
method described by Papillo et al. (2014), slightly modified.50 The scheme of the adopted 
experimental protocol is reported in Figure 2.1.. 
Briefly, four sequential digestive phases, namely simulated salivary phase (SSP), gastric 
phase (SGP), duodenal phase (SDP) and colon phase (SCP), including Viscozyme L and 
Pronase E steps, were carried out. PPe (2.5 g), grinded PPeC (2.5 g), cellulose (2.5 g, as 
control for PPe) and grinded CTC (2.5 g) were submitted to the enzymatic digestion. At each 
step, the supernatants were collected for the HPLC analysis and for the measure of the total 
antioxidant capacity (TAC), whereas the pellets were analyzed for the evaluation of insoluble 
TAC. Before the analysis, the supernatants were  further centrifuged (4000 rpm for 30 min at 
4°C), ultra-centrifuged (14800 rpm for 15 min at 4°C)  and different aliquots (one milliliter 
each) of digestive extracts were carefully dried under nitrogen flow, in order to preserve the 
samples. 
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Fig. 2.1. Flow chart of the experimental design. Enzyme inhibition assays were performed only for PPeC. 
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2.2.5 HPLC analysis 
For the HPLC analysis of soluble fractions, the aliquots of digestive extracts were re-
suspended in 1 mL of a solution water/methanol (50:50, v/v) at 0.5 % of formic acid and 
properly diluted. The chromatographic separation of ETs, EA, EAs and GA from the 
supernatants at each digestion step was obtained according the methods described by Seeram 
et al. (2004), with slight modifications.51,52 The HPLC system consisted in two binary pumps 
(LC-10AD, Shimadzu, Kyoto, Japan), equipped with a photo-diode array detector (SPD-
M10A, Shimadzu, Kyoto, Japan) and a C-18 reversed phase column Gemini 5μ 250 mm x 4.6 
(Phenomenex, Torrance, CA) was used. The flow rate was 0.8 mL/min and the mobile phases 
were water at 2% of formic acid (phase A) and methanol (phase B); the following gradient 
was applied: [min]/[%B] - (0/0), (20/10), (30/30), (35/40), (40/70), (45/98), (48/98), (50/0), 
(52/0). The injection volume was 20 μl. ETs, EA, EAs and GA were identified by LC-MS/MS 
with an API 3000 Triple Quadrupole mass spectrometer (Applied Biosystem Sciex). Mass 
spectrometry conditions were optimized, according to Fischer et al., (2011).26 ETs, including 
punicalin (anomers α and β), punicalagin (anomers α and β), pedunculagin (anomers α and β) 
and a compound previously identified by Fischer et al., (2011) as a castalagin derivative, were 
detected and quantified at 378 nm. For EA, EAs and GA, the wavelengths used were 366 nm 
and 280 nm, respectively. Calibration curves of punicalagin, EA and GA were obtained. 
Punicalagin, EA and GA were identified and quantified with the corresponding standards. 
Punicalin anomers, pedunculagin anomers, castalagin derivative and total ETs were quantified 
as punicalagin equivalents. EAs, including ellagic acid hexoside, pentoside and 
deoxyhexoside, were quantified as EA equivalents. 
2.2.6 Total antioxidant capacity of soluble and insoluble fractions 
The total antioxidant capacity (TAC) of soluble and insoluble fractions obtained by each 
digestive step, was measured with a spectrophotometer (PG Instruments, UK) set at 517 nm, 
using respectively the DPPH method and DPPH QUENCHER method, as previously 
described by Papillo et al., (2014).50 Before the analysis, the dried aliquots of the soluble 
fractions were re-suspended in 1 mL of water and the insoluble pellets obtained after each 
digestion step were freeze dried. The results were expressed as mmol of Trolox equivalents 
(TE)/kg of dry matter (DM). 
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2.2.7 α-glucosidase inhibition assay 
The assay was carried out as reported by Chandran et al. (2015), with slight modifications.53 
The aliquots of extract from SDP, previously dried under nitrogen flow, were re-suspended in 
distilled water and appropriately diluted. Subsequently, 125 μL of this solution were added to 
870 μL of 0.1 M phosphate buffer (pH 6.8). Then, 125 μL of a 0.1 M phosphate buffer 
solution (pH 6.8) containing the enzyme α-glucosidase from Saccharomyces cerevisiae (1 
U/mL) were added. The reaction was started adding to the mixture, 125 μL of a 0.1 M 
phosphate buffer solution containing para-nitrophenyl-α-d-glucopyranoside (3 mM) as 
substrate for the enzyme. The samples were incubated for 20 min at 37°C, in a shaking 
thermostatic bath. The amount of released p-nitrophenol was determined 
spectrophotometrically, measuring the absorbance of the solution at 405 nm. Percent 
inhibition was calculated as follows: 
[(Abs 100% −  Abs 0%) − (Abs sample −  Abs blank)]
(Abs 100% −  Abs 0%)
× 100 
 
where: 
Abs 100% was the absorbance of 100 % enzyme activity (in the reaction mixture only the 
enzyme and the substrate); Abs 0% was the absorbance of 0% enzyme activity (in the reaction 
mixture only the substrate without enzyme); Abs sample was the absorbance of the reaction 
mixture, containing substrate, enzyme and the tested extract; Abs blank was the absorbance of 
the reaction mixture without enzyme and containing only the substrate and tested extract. 
2.2.8 α-amylase inhibition assay 
The capacity of SDP to inhibit the activity of α-amylase was investigated as reported by Dey 
et al., (2014), with slight modifications.54 
The dried aliquots of SDP extracts were reconstituted in 1 mL of distilled water and properly 
diluted. The starch Azure was used as substrate. Particularly, 4 mg of starch Azure were 
suspended in 0.4 mL of a 0.1 M Tris-HCl buffer (pH 6.9), containing calcium chloride (0.01 
M) and the solution was boiled for 5 minutes and pre-incubated 5 minutes at 37°C. Then, 0.4 
mL of extract diluted in 0.1 M Tris–HCl buffer (pH 6.9) were added to the substrate. Finally, 
the reaction was started adding 0.2 mL of a 0.1 M Tris-HCl buffer solution (pH 6.9), 
containing α-amylase from porcine pancreas (2 U/mL). The reaction mixture was incubated 
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10 minutes at 37 °C, in a shaking thermostatic bath. The reaction was stopped by adding 1 mL 
of 50% (v/v) acetic acid solution. Afterwards, the samples were ultra-centrifuged at 14800 
rpm for 10 min. at 4°C. The absorbance of supernatant was measured at 595 nm with a 
spectrophotometer (PG Instruments, UK). Percent inhibition was calculated, as follows: 
[(Abs 100% −  Abs 0%) − (Abs sample −  Abs blank)]
(Abs 100% −  Abs 0%)
× 100 
where:  
Abs 100% was the absorbance of 100 % enzyme activity (in the reaction mixture only the 
enzyme and the substrate); Abs 0% was the absorbance of 0% enzyme activity (in the reaction 
mixture only substrate without enzyme); Abs sample was the absorbance of the reaction 
mixture, containing substrate, enzyme and the tested extract; Abs blank was the absorbance of 
the  reaction mixture without the enzyme and containing only the substrate and tested extract. 
2.2.9 Lipase inhibition assay 
Lipase inhibition assay was carried out with a method adapted by Mennella et. al., (2014).55  
Preliminarily, one milliliter of SDP extract, previously dried under nitrogen flow, was 
resuspended in one milliliter of distilled water and appropriately diluted. One milliliter of 0.1 
M Tris–HCl buffer  solution (pH 8.3), containing 0.3 mM 5-5′-dithio-bis (2-nitrobenzoic acid) 
(DTNB), was mixed with 50 μl of 0.1 M Tris–HCl buffer solution (pH 8.3) containing the 
enzyme (0.05 U/mL) and 40 μl of the solution of intestinal extract. Then, 80 μL of 20 mM 
2,3-dimercapto-1-propanol tributyrate (dissolved in ethanol) were added in order to start the 
reaction. The samples were incubated in a shaking thermostatic bath for 30 min at 37°C. The 
lipase released 2,3-dimercapto-1-propanol that reacted with DTNB to release TNB anions 
(yellow colour). Tubes were centrifuged at 14800 rpm for 10 min at 4°C and the absorbance 
was measured at 412 nm with a spectrophotometer (PG Instruments, UK). Percent inhibition 
was calculated as follows:  
[(Abs 100% −  Abs 0%) − (Abs sample −  Abs blank)]
(Abs 100% −  Abs 0%)
× 100 
 
where:  
Abs 100% was the absorbance of 100 % enzyme activity (in the reaction mixture only the 
enzyme and the substrate); Abs 0% was the absorbance of 0% enzyme activity (in the reaction 
mixture only substrate without enzyme); Abs sample was the absorbance of the reaction 
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mixture containing substrate, enzyme and the tested extract; Abs blank was the absorbance of 
the reaction mixture without enzyme and containing only the substrate and tested extract. 
2.2.10 Statistical analysis 
According to Papillo et al., (2014),50 the TAC of all the soluble fractions plus the TAC of the 
last insoluble residue were used to calculate the overall potential TAC (OP-TAC), of which 
the FREE-TAC was related to the SSP, while the BOUND-TAC was due to the soluble 
fractions collected in all the steps plus the last residue. In addition, the total amount of ETs, 
EAs and GA released at all digestion steps were used to calculate the overall bioaccessible 
ETs (OB-ETs), EAs (OB-EAs) and GA (OB-GA), respectively. The amount of each class of 
compounds released in the SSP were the FREE-ETs, FREE-EAs and FREE-GA, while the 
amount released after SSP (from stomach to colon) were the BOUND-ETs, BOUND-EAs and 
BOUND-GA. The sequential enzymatic digestion was performed in triplicate and all the 
samples were always analysed in triplicate. The data were analysed by ANOVA, and the 
mean values were compared by Tukey test (α = 0.05), using XLStat statistical software 
(Addinsoft, New York, NY). The Pearson correlation coefficient was used for the bivariate 
correlation analysis between variables (α = 0.05). 
 
 
  
Chapter 2 In vitro bioaccessibility and functional properties of polyphenols from pomegranate peels and 
pomegranate peels-enriched cookies 
43 
2.3 Results 
2.3.1 PPe dietary fiber 
TDF content of PPe powder was 48 g/100g of PPe, whose 72.9% was IDF and 27.1% was 
SDF. 
2.3.2 Bioaccessibility of polyphenols from PPe and from PPeC 
Punicalin anomers, punicalagin anomers, pedunculagin anomers, castalagin der., GA , EA and 
three EAs were identified and quantified in the extracts of each step of simulated in vitro 
digestion of PPe and PPeC whereas they were absent in cellulose and CTC. The results were 
summarized in Table 2.1. 
The total amount of bioaccessible ETs, EAs and GA from PPe were 7666.3 mg/100g of PPe 
powder, of which the 42.8% (3278.7 mg/100g of PPe powder) were immediately released in 
the SSP, the 52.0% were potentially bioaccessible in the upper GiT and the 5.2% were 
potentially bioaccessible only after in the SCP. 
The total amount of bioaccessible ETs, EAs and GA from PPeC was 491.1 mg/100g of PPeC, 
of which 223.2 mg (45.4%) were from the salivary phase, thus being potentially bioaccessible 
early in the proximal GiT, while the remaining part 267.9 mg (54.6%) were released in the 
next steps. In particular, 216.8 mg/100g of PPeC (44.1% of the total polyphenols released) 
were potentially bioaccessible in the upper GiT (stomach and duodenum) after the action of 
pepsin and pancreatin, while 51.1 mg (10.4% of the total polyphenols released) were 
potentially bioaccessible 233 in the lower GiT (colon) after Pronase E and Viscozyme L 
action. The extract from SSP was mainly constituted by both punicalagin and EA, whereas the 
subsequent extracts were mainly constituted by EA. 
In Table 2.2., the values of overall bioaccessible (OB)-polyphenols (i.e. OB-ETs, OB-EAs, 
OB-GA), as well as the percentage of free-polyphenols (i.e. FREE-ETs, FREE-EA, FREE-
GA) and bound polyphenols (i.e. BOUND-ETs, BOUND-EAs and BOUND-GA) for both 
PPeC and for PPe were reported. Data showed that despite huge differences of repartition 
between free and bound fractions of specific polyphenols out of the overall bioaccessible 
amount from PPe and PPeC, similar percentages for total polyphenols were found. 
 
Chapter 2 In vitro bioaccessibility and functional properties of polyphenols from pomegranate peels and pomegranate peels-enriched cookies 
44 
 
Table 2.1. Concentrations (mg/100g) of polyphenols released upon enzymatic digestion of PPe and PPeC. For PPeC the percentage variation (Var.) of each concentration vs the 
expected concentration was also reported. Expected concentrations were calculated on the basis of data obtained by PPe in vitro digestion, taking into account the enrichment of 
PPe in PPeC (7.5% by weight). Values were expressed as mean ± SD. For each compound, values in the same row followed by different lowercase letter (for PPe digestion) or 
different uppercase letter (for PPeC digestion) are significantly different (p < 0.05) according to Tukey's test.  
# mg of punicalagin equiv.+ mg of EA equiv. + mg of GA equiv. HE: Hexoside; PE: Pentoside; DHE: Deoxyhexoside; < LOD: Lower than the limit of detection; n.a.: not 
available.
 
Simulated salivary phase Simulated gastric phase Simulated duodena lphase Simulated colon phase Total 
Compounds 
PPe PPeC Var.  PPe PPeC Var.  PPe PPeC Var.  PPe PPeC Var.  PPe PPeC Var.  
mg/100g mg/100g (%) mg/100g mg/100g (%) mg/100g mg/100g (%) mg/100g mg/100g (%) mg/100g mg/100g (%) 
Punicalin 855.9± 193.0 a 33.1 ± 1.4 A -48 924.1± 60.9 a 11.8 ± 2.5 B -83 240.1 ± 17.9 b 4.3 ± 0.1 C -76 62.3 ± 2.9 b < LOD n.a. 2082.4 ± 166.3 49.2 ±  1.2  -68 
Punicalagin 1491.6± 122.4 a 57.0± 8.0 A -48 1039.8± 62.1 b 22.9± 1.4 B -70 426.6 ± 54.9 c 14.9 ± 3.2 B -53 74.1 ± 16.7 d < LOD n.a. 3032.1 ± 218.2 94.8 ± 9.8  -58 
Pedunculagin 62.1± 14.4 a 2.4 ± 0.4 A -48 23.9 ± 3.1 b 1.1 ± 0.5 B -39  15.3 ± 3.1 b,c < LOD n.a. 0.7 ± 0.1 c < LOD n.a. 102.0 ± 18.4 3.5 ± 0.3 -53 
Castalaginder. 73.3± 6.3 c 43.4 ± 6.5 B 704 15.9 ± 2.3 d 1.5 ± 0.4 D 25 569.2± 18.4 a 61.3± 2.7 A 46 181.7 ± 7.1 b 16.3 ± 0.8 C 22 840.1 ± 19.8 122.4±  8.7 97 
ETs 2482.9± 70.9 a 135.9 ± 16.0 A -26 2003.7± 114.1 b 37.2 ± 4.0 C -75 1251.2± 78.5 c 80.5 ± 5.9 B -13 318.8 ± 20.7 d 16.3 ± 0.8 D -31 6056.6 ± 156.9 270.1 ± 17.2 -40 
Ellagic acid HE 88.2± 4.6 a 3.8 ± 0.7 A -42 41.4 ± 0.9 b 2.1 ± 0.2 B -32 20.2 ± 0.2 c 1.9 ± 0.1 B 27 5.3 ± 0.3 d 0.6 ± 0.0 C 50 155.1 ±  5.2 8.4 ± 0.4 -27 
Ellagic acid PE 23.3± 0.4 a 1.6 ± 0.3 A -6 < LOD 0.3 ± 0.1 C n.a. 8.0± 0.1 b 1.0 ± 0.1 B 67 2.8 ± 0.1 c 0.3 ± 0.0 C 50 34.1 ± 0.3  3.2 ± 0.4  28 
Ellagic acid 
DHE 
29.6± 2.8 a 1.7 ± 0.1 A -23 12.3 ± 3.6 b 0.7 ± 0.1 C  -22 9.9 ± 1.8 b 1.0± 0.1 B 43 2.6 ± 0.1 c 0.2 ± 0.0 D 0 54.4 ± 8.2 3.6 ±  0.1  -10 
Ellagic acid 537.5± 12.3 a 55.9 ± 5.3 B 40 341.4 ± 71.3 b 14.6 ± 0.6 D -42 136.8± 1.1 c 69.1± 0.3 A 584 59.6 ± 5.2 d 33.5 ± 0.7 C 661 1075.2 ± 86.4 173.1± 4.0 117 
EAs 678.6± 13.7 a 63.0 ± 6.4 B 25 395.1 ± 68.5 b 17.7 ± 0.8 D -39 174.9± 3.0 c 73.1 ± 0.3 A 467 70.3 ± 4.9 d 34.6 ± 0.8 C 565 1318.8 ± 83.0 188.4 ± 4.6 93 
Gallic acid 117.3± 14.2 a 24.3± 1.9 A 179 103.2 ± 1.7 a 7.5 ± 1.2 B -1 57.5 ± 1.2 b 0.8 ± 0.2 C -81 12.9 ± 0.1 c < LOD n.a. 291.0 ± 16.5 32.6± 0.9 52 
ETs + EAs + 
GA # 
3278.7± 90.0 a 223.2 ± 24.3 A -8 2502.0± 77.7 b 62.5± 6.1 C -66 1483.6± 80.0 c 154.3± 6.0 B 41 402.0 ± 25.5 d 51.1 ± 1.5 C 72 7666.3 ± 122.9 491.1± 22.7 -13 
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Table 2.2. Overall bioaccessible-ETs (OB-ETs), Overall bioaccessible-EAs (OB-EAs) and Overall 
bioaccessible-GA (OB-GA), for PPe and PPeC,. FREE-ETs, FREE-EAs and FREE-GA corresponded to the 
amount released in the SSP while the amount released later on the digestion were the BOUND-ETs, BOUND-
EAs and BOUND-GA. 
  Compounds Overall 
bioaccessible 
(mg/100g) 
Free 
(mg/100g) 
Free 
(%) 
Bound 
(mg/100g) 
Bound 
(%) 
PPe 
ETs 6056.6 ± 156.9 2482.9 ± 70.9 41 3573.5 ± 169.4 59 
EAs 1318.8 ± 83.0 678.6 ± 13.7 51 640.3 ± 70.4 49 
GA 291.0 ± 16.5 117.3 ± 14.2 40 173.7 ± 2.7 60 
Total 7666.3 ± 122.9 3278.7± 90.0 43 4387.6 ± 116.7 57 
PPeC 
                      
ETs 270.1 ± 17.2 135.9 ± 16.0 50 134.2 ± 1.6 50 
EAs 188.4 ± 4.6 63.0 ± 6.4 33 125.4 ± 1.8 67 
GA 32.6 ± 0.9 24.3 ±  1.9 75 8.3 ± 1.0 25 
Total 491.1 ± 22.7 223.2 ± 24.3 45 267.9 ± 2.4 55 
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2.3.3 Total antioxidant capacity 
Figure 2.2. reported the TAC of soluble and insoluble fractions after each step of the in vitro 
digestion of both PPe that PPeC.  
 
Figure 2.2. TAC of soluble and insoluble fractions from simulated gastrointestinal digestion of PPe and PPeC. 
Mean values were expressed as mmol of TE/kg of DM. Both for PPe and for PPeC digestion steps, different 
lower case letter (for soluble TAC) and upper case letter (for insoluble  TAC) indicate significantly different 
values (p < 0.05) according to Tukey's test. 
 
Data obtained by PPe digestion showed that the TAC of fractions solubilized gradually 
decreased along the GiT. The TAC of insoluble fraction (pellet) after SCP (colon) was higher 
than that obtained after SGP, thus indicating that a great amount of TAC was released after 
the disruption of the DF matrix in PPe. 
Chapter 2 In vitro bioaccessibility and functional properties of polyphenols from pomegranate peels and 
pomegranate peels-enriched cookies 
47 
 
Similarly, during PPeC digestion, the TAC of the fraction solubilized in the SSP was always 
higher than the others but a higher TAC of the SDP than SGP extract was observed. The 
insoluble TAC found for PPeC followed the same trend along the digestive steps as for PPe, 
except the TAC of SCP pellet that was only a bit higher than that relative to SDP. 
The FREE-TAC and BOUND-TAC were evaluated both for PPe and for PPeC. For PPe, the 
values of FREE-TAC and BOUND-TAC were 3307 mmol TE/kg of DM (29% of OP-TAC) 
and 7933 mmol TE/kg of DM (71% of OP-TAC), respectively. BOUND-TAC calculated for 
the extracts after the SGP, SDP and SCP were 26%, 23% and 16% of the total OP-TAC, 
respectively. 
Likewise, for PPeC, FREE-TAC and BOUND-TAC were 162 mmol TE/257 kg of DM (31% 
of OP-TAC) and 360 mmol TE/kg of DM (69% of OP-TAC), respectively. The values of 
BOUND-TAC calculated for the extracts after the SGP, SDP and SCP were 21%, 25% and 
17% of the total OP-TAC, respectively. 
 
Figure 2.3. Comparison among OP-TAC values of PPe and PPeC and OP-TAC of 5 common plant foods as 
reported by Papillo et al., (2014).50 Values are expressed as mmol of TE per kg of DM. 
 
The OP-TAC calculated for PPe and PPeC were 11240 mmol TE/kg of DM and 522 mmol 
TE/kg of DM, respectively. In Figure 2.3., the values of OP-TAC calculated for PPE and 
PPeC were compared with the values of OP-TAC, calculated for five common plant foods. 
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2.3.4 Inhibition of enzyme activity 
SDP extracts from PPeC digestion were tested in order to assay their capacity to inhibit in 
vitro α- amylase, α-glucosidase, and lipase. The results were reported in Figure 2.4. Data 
demonstrated that SDP strongly inhibited α-glucosidase activity, while a weak inhibitory 
capacity against α-amylase and lipase was found. This effect was due to the whole mixture of 
polyphenols (ETs, EA, EAs and GA) present in SDP extract. It was calculated that 0.007 mg 
of polyphenols in SDP extract inhibited by 84% the activity of 1 U of α-glucosidase, whereas 
about 5 (0.036 mg) and 80 (0.578 mg) greater amounts of the same mixture of polyphenols 
were necessary to inhibit by 72% and by 13% 1 U of α-amylase and 1 U of lipase, 
respectively. 
 
Figure 2.4. Enzyme inhibition rate of extracts from SDP of PPeC. The dilution factors of the tested extracts, 
compared with the initial concentration, were 30, 6 and 6, for α-glucosidase, α-amylase and lipase, respectively. 
Data were corrected for the inhibition elicited by CTC. 
2.4 Discussion 
For the first time in this study the potential TAC and bioaccessibility of polyphenols from a PPe 
powder and a PPe-enriched baked food, as well as their ability to inhibit the activity of α-amylase, 
α-glucosidase and lipase, were evaluated upon an in vitro simulated gastrointestinal digestion. PPeC 
developed in this study contained 7.5% of PPe, providing 491.1 mg/100g of PPeC of overall 
bioaccessible polyphenols (mainly ETs and EA), and 3.6 % of DF according to Hasnaoui et al. and 
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Viuda-Martos et al..28,56 This formulation guaranteed sensory acceptability of the product according 
to Ismail et al.41 and Srivastava et al.57 and allowed the nutritional claim of "source of dietary fiber" 
according to European Commission Regulation 1924/2006 and European Food Safety Authority 
(EFSA).58,59 
Previous in vivo study demonstrated that under physiological conditions ETs are partially 
hydrolyzed and release EA. EA is then gradually metabolized in the intestine to produce bioactive 
urolithin D, urolithin C and finally urolithin A and urolithin B in the distal parts of the intestine.31 
Interestingly, our data showed that the potential bioaccessibility of ETs was 40% lower while that 
of EAs and GA was respectively 93% and 52% higher from PPeC than PPe. In particular, 
comparing the release of polyphenols obtained from PPeC upon the in vitro digestion with the 
expected values extrapolated from the data obtained for PPe, and taking into account the enrichment 
of PPe in PPeC (7.5% by weight), data showed (Table 2.1.) a 13.4% reduced overall release of 
polyphenols from PPeC compared to the expected concentration. This total difference was due to a 
halved release of ETs, and a doubled and a 1.5 fold increased release of EAs and GA from PPeC 
compared to the expected values, respectively. It is likely that during the process to produce 
cookies, ETs (mainly punicalin and punicalagin) and EA present in PPe, partially hydrolyzed by 
forming EA and GA, respectively, in PPeC.60 Moreover, it was hypothesized that some of ETs, 
such as castalagin der., could become more bioaccessible from PPe under cookies processing 
because a double amount (122.4 mg/100g of PPeC vs 62.2 mg/100g of PPeC) was retrieved in the 
solubilized fractions after in vitro digestion compared to the expected amount. Interestingly, looking 
at the step by step release of castalagin der. upon the simulated gastrointestinal digestion, data 
showed that the 63.1% of the increased release occurred in the SSP whereas the 31.9% and the 
4.8% were released in the SDP and in the SCP, respectively. On the other hand, the newly formed 
GA in PPeC was completely released in the SSP (140%) while the newly formed EAs were released 
by 66% and by 32% in the SDP and SCP respectively and only the 14% was present in the SSP. 
These data demonstrated that the complex food matrix of PPeC, mainly including starch and the 
gluten network together with PPe, strongly influenced the release of EAs, mainly EA, so that the 
enzyme action of pepsin and pancreatin was necessary to allow their delivery from the food matrix. 
This happened because polyphenols can interact with food macronutrients through covalent and 
non-covalent interactions, the resultant affinity being also influenced by the water solubility of 
polyphenols: higher is the water-solubility lower is the affinity with non-polar food matrices.61-64 
EA is much less soluble in water than ETs and GA, thus potentially forming stronger hydrophobic 
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interactions with the water insoluble gluten matrix of PPeC, and being mostly released after the 
disruption of that matrix compared to its more water-soluble glycosylated derivatives (mainly 
detected in the SSP).29,31 In other words, data showed that the use of PPe as ingredient in the 
cookies determined a different bioaccessibility of the constituent polyphenols compared to the PPe 
powder, thus influencing the related potential antioxidant protection. In fact, a significant 
correlation among the total amount of ETs, EAs and GA, released at each digestive step, and the 
values of TAC measured for the corresponding soluble extracts, both for PPe (r = 0.983; p = 0.017) 
and for PPeC (r = 0.969; p = 0.031) was observed. Moreover, the effect of digestive enzymes on the 
two types of matrix (PPe and PPeC) caused a different behavior of the un-solubilized materials at 
each digestive step. In particular, results showed that, insoluble fractions of PPe and PPeC after the 
SCP, i.e. after the action of bacterial proteases and cellulolytic enzyme mixture, exhibited a higher 
antioxidant activity than the insoluble material obtained by the SDP. 
The potential antioxidant protection in the gut demonstrated in vitro in this study might be at the 
basis of the reduced colon inflammation and positive modulation of the gut microbiota induced by 
PPe in obese mice fed with a high-fat diet.65 
In PPe, like in cereals, fruits and vegetables, polyphenols are found free or covalently bound to cell 
wall structural components, such as arabinoxylans, cellulose and lignin, or to proteins.66 So, once 
ingested the action of digestive enzymes allows the polyphenols to be delivered by the food matrix 
and act against reactive oxygen species (ROS), along the GiT.12,13,50 On the other hand the 
destruction of the matrix operated by the enzymes allows the bound polyphenols  to dispose on th 
surface of the un-solubilized material and to act as a sponge of free radicals along the GiT before 
arriving to the colon and be delivered by the gut microbiota enzymes.13 
Mounting evidence indicate that the interactions among the gut microbiota, DF and polyphenols 
may have implications on the prevention of obesity risk. The potential antioxidant activity along the 
GiT, demonstrated in this study by PPe and PPeC, is perfectly in line with the conclusion driven by 
Al-Muammar and Khan, that the prevention of obesity risk, associated with consumption of 
pomegranate products, is correlated to their antioxidant compounds released along the GiT.38 Data 
of the present study showed that values of FREE-TAC were 29% and 31% of OP-TAC, for PPe and 
PPeC, respectively. These results were similar to those obtained for apple (32%) and spinach (29%) 
in a previous study from our research group, and a bit lower than those relative to walnuts (42%).50 
However, PPe exhibited an OP-TAC that was about ten times higher than the OP-TAC calculated 
for the walnuts (see Figure 2.3.). This was in line with the huge abundance of the whole mix of 
antioxidants (ETs, EA, EAs and GA) in pomegranate by-products (85 g/kg of d.w.) compared to 
Chapter 2 In vitro bioaccessibility and functional properties of polyphenols from pomegranate peels and pomegranate 
peels-enriched cookies 
51 
 
walnuts (1.8 to 3.0 g for kg of fresh weight), particularly to the higher relative abundance of 
hydrolysable tannins in pomegranate by-products (about 99.5%) than in walnuts kernels (about 
76.3%).26,67 In fact, compared to other polyphenols, hydrolysable tannins are recognized highly 
antioxidants and very active inhibitors of free radicals. These effects were directly correlated to 
their molecular weight and to the number of reactive galloyl groups in the molecules.68 Punicalagin 
is recognized as one of strongest antioxidant compound and major responsible of the high 
antioxidant capacity of pomegranate juice being 16 folds more antioxidant than EA and 7 folds 
more antioxidant than GA.26,27,69 
Together with the antioxidant potential, our data also indicated that PPeC could influence glucose 
metabolism and lipid digestion by modulating activity of α-glucosidase, α-amylase and lipase. 
Starch is the most common complex carbohydrate in foods, and its digestion in  the GiT is mainly 
mediated by α-amylase and α-glucosidase. The rate of glucose release in the GiT modulate energy 
homeostasis and fine physiological mechanisms underlying hunger and satiety.70 
The findings of the present study indicated that the soluble extract from SDP strongly inhibited α-
glucosidase and, at a lesser extent, α-amylase. The results on α-glucosidase inhibition were 
consistent with those previously obtained by Li et al.39 with PPe phenolics and those obtained by 
Cam et al.71 with a functional ice cream containing PPe  phenolics-enriched microcapsules. 
The use of α-glucosidase from Saccharomyces cerevisiae in the present study could be considered 
as a limitation because it is known that the extent of activity of α-glucosidase inhibitors may vary 
according to the origin of α-glucosidase, i.e. if they are α-glucosidase from yeast or from 
mammalians.72-75 However, in previous studies polyphenols from PPe extracts mainly including 
punicalagin, punicalin and ellagic acid strongly inhibited in vitro rat intestinal α-glucosidase and 
recombinant human maltase–glucoamylase but exhibited weak or no inhibitory effects against 
porcine pancreatic α-amylase.34,36,76 So, it might be speculated that the results found in the present 
study using a pure yeast α-glucosidase might be found also using a mammalian enzyme, but future 
studies are warranted to demonstrate this hypothesis. 
On the other hand, lipase is the major enzyme responsible for the gastrointestinal digestion of 
dietary triglycerides into monoglycerides and free fatty acids. The inhibition of pancreatic lipase 
along the GiT could result in a reduced lipid absorption and in a consequent reduced energy 
intake.The weak inhibitory effect of SDP extract on lipase activity was in line with results 
previously obtained in vitro and with the in vivo evidence that consumption of a pomegranate leaf 
extract could inhibit the development of obesity and hyperlipidemia in high-fat diet induced obese 
mice also through inhibition of the pancreatic lipase activity.15,40 
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2.5 Conclusion 
In conclusion, the findings of the present study support the use of PPe at a dose of 7.5% by weight 
in bakery food products, as a functional ingredient to counteract oxidative stress along the GiT. The 
potential antioxidant protection may involve all the organs of the GiT due to the release of ETs, EA, 
EAs and GA along all the digestive system. Moreover it was demonstrated that the baking process 
increased the amount of EA in the PPeC due to chemical degradation of ETs, thus allowing its 
increased release in the duodenal and colon phase compared to the raw ingredient. In fact, food 
matrix strongly influenced both the release of polyphenols in the different steps as well as the 
antioxidant potential of the un-solubilized material. Together with a high antioxidant potential, the 
mix of polyphenols solubilized in the SDP also acted as strong inhibitors of α-glucosidase thus 
possibly influencing in a positive manner the glucose metabolism in vivo. In vivo studies are 
warranted to evaluate the sensory properties of the PPeC developed in this study and its effects on 
oxidative stress and on glucose and lipid metabolism. 
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2.6 Abbreviations 
CTC: Control cookies 
DF: Dietary fiber 
EA: Ellagic acid 
EAs: Ellagic acid derivatives 
ETs: Ellagitannins 
GA: Gallic acid 
GiT: Gastrointestinal tract 
PPe: Pomegranate peels 
PPeC: Pomegranate peels-enriched cookies 
SCP: Simulated colon phase 
SDP: Simulated duodenal phase 
SGP: Simulated gastric phase 
SSP: Simulated salivary phase 
TAC: Total antioxidant capacity 
TE: Trolox equivalents 
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Abstract 
Globe artichoke (Cynara cardunculus L. var. scolymus) by-products from industrial processing 
mainly include stems and external leaves. They may be natural and sustainable source of 
polyphenols (PPs) and dietary fiber for the formulation of functional foods.  
In this study an artichoke stem powder (ASP) was used at three concentrations (3%, 6% and 
9%), in substitution of wheat flour, for the formulation of new breads. The potential 
bioaccessibility of PPs and cynaropicrin from the ASP-enriched breads was evaluated in vitro by 
using a digestion model coupled to High Resolution Mass Spectrometry (HRMS) analysis. The 
overall total antioxidant capacity (TAC) of the bioaccessible and unsolubilized fractions obtained 
at the duodenum and colon steps were tested together with the ability of ASP-enriched breads to 
modulate α-glucosidase activity.  
Data showed that most of PPs and cynaropicrin (about 82% and 74% of total bioaccessible 
amount) were mainly released at the duodenum step of digestion but caffeic acid that was mainly 
released in the colon (about 88%). PPs released in the duodenal step showed an antioxidant 
activity and an inhibitory capacity towards α-glucosidase correlated with the amount of ASP 
added in the bread. 
In conclusion it was demonstrated that ASP-enriched breads allowed the release of PPs, 
cynaropicrin and antioxidant activity along the gastro-intestinal tract and modulated 
carbohydrate metabolism in vitro.  
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3.1 Introduction 
Globe artichoke (Cynara cardunculus L. var. scolymus) is a vegetable distributed worldwide and 
mainly cultivated  in the Mediterranean regions. Italy is the first world producer (451461 
tons/year) followed by Egypt (266196 tons/year) and Spain (234091 tons/year).1 The immature 
inflorescence (capitula or head) represents the edible part of the plant and is consumed fresh, 
frozen, or canned.2 Stems and external leaves represent about 80-85 % of the total fresh weight 
of the plant and are the main artichoke by-products from industrial processing.3 
Both the edible parts and the by-products are well known sources of dietary fiber (DF) and 
polyphenols (PPs), mainly including caffeoylquinic acids (CQA), di-caffeoylquinic acids 
(DCQA) and flavones.3-6 Chlorogenic acid (5-O-caffeoylquinic acid), 1,5-di-O-caffeoylquinic 
acid and 3,5-di-O-caffeoylquinic acid are the most abundant phenolic acids in artichoke tissues, 
whereas luteolin and apigenin glycosides and rutinosides derivatives are the most abundant 
flavones.3,4,7,8 These molecules exert in vitro antioxidant, antimicrobial and anticarcinogenic 
activities, they can modulate the endothelial-type nitric-oxide synthase gene expression and act 
as natural inhibitors of key enzymes in metabolic syndrome development.9-17 Moreover, several 
animal and human studies highlighted the health benefits associated to the intake of artichoke 
bioactive compounds, mainly including prebiotic effects on  colonic microbiota as well as 
hepatoprotective, antioxidative, hypolipidemic, hypoglycemic, anti-inflammatory, anti-
dyspeptic, cholesterol lowering, anti-obesity and bile-expelling effects.18-33 These effects were 
mostly associated to the ability of artichoke caffeoylquinic acids and flavonoids to modulate 
cellular antioxidant defense systems and the activity of some digestive enzymes.34 
Sesquiterpene lactones, including guaianolides, represent another class of compounds present in 
artichoke (mainly in the leaves) and having several biological properties such as anti-
hyperlipidemic and anti-photoaging activities.35,36 Cynaropicrin is the most abundant, accounting 
for the 80% of bitter taste of artichoke.37,38 This compound and the grosheimin can activate in 
vitro the human bitter taste receptor hTAS2R46 at very low concentrations.39 This property may 
contribute to the metabolic benefits mostly associated to the consumption of artichoke DF and 
PPs. Indeed, mounting evidence shows that bitter compounds modulate neurohormonal response 
behind gastrointestinal motility, glucose homoeostasis and appetite control through the activation 
of bitter taste receptors located along the gastrointestinal tract (GiT).40-44 
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The presence of a multitude of bioactive compounds in artichoke by-products make them a good 
source of functional ingredients to add in food as already proposed by some researchers.5,45-49 
Despite the undisputable social value to valorize agricultural by-products, their use as functional 
ingredients in new food matrices need a bio-efficacy validation. In fact, both food processing and 
structure may influence the chemical composition and the bioavailability of bioactive 
compounds from the enriched-foods.50,51 The bioaccessibility, the bioavailability and the 
potential antioxidant effects along the GiT of PPs from artichoke heads, were previously studied 
both in vivo and in vitro.21,52-54 Scientific literature is still lacking on the bioaccessibility and 
potential bio-efficacy of bioactive compounds from foods enriched with artichoke by-products. 
In this study the stems were selected among artichoke by-products and used at 3%, 6% and 9% 
in the formulation of new types of bread. The potential bioaccessibility of PPs and cynaropicrin 
from the breads as well as the overall total antioxidant capacity (TAC) and potential ability to 
modulate α-glucosidase activity in the GiT were assessed. 
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3.2 Material and methods 
3.2.1 Chemicals 
Water, methanol and acetonitrile were obtained from Merck (Darmstadt, Germany). Ethanol and 
formic acid were purchased from VWR international (Fontenay-sous-Bois, France). Cellulose 
powder was obtained from Fluka (Buchs, Switzerland). Total dietary fiber assay kit was 
purchased from Megazyme International (Wicklow, Ireland). Calcium chloride, potassium 
chloride, sodium chloride, potassium phosphate monobasic, magnesium chloride hexahydrate, 
ammonium carbonate, 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox), 2,2-
diphenyl-1-picrylhydrazyl, 95% (DPPH), sodium bicarbonate, sodium hydroxide, hydrochloric 
acid, celite, 5,5′-Dithiobis(2-nitrobenzoic acid), tris(hydroxymethyl)-
aminomethane hydrochloride, 4-morpholinoethanesulfonic acid (MES), para-nitrophenyl-α-d-
glucopyranoside, sodium phosphate dibasic heptahydrate (≥ 99,99% trace metals basis) were 
purchased from Sigma-Aldrich (St. Louis, MO). α-amylase from porcine pancreas (type VI-B ≥ 
10 U/mg), α-glucosidase from Saccharomyces cerevisiae (Type I ≥ 10 U/mg), protease from 
Streptomyces griseus, (Pronase E, Type XIV ≥ 3.5 U/mg), cell wall degrading enzyme complex 
from Aspergillus sp. (Viscozyme L), pancreatin from porcine pancreas (4 X USP) and pepsin 
from porcine gastric mucosa (≥ 250 U/mg) were purchased from Sigma-Aldrich (St. Louis, MO). 
Analytical standards of cynarin, chlorogenic acid, and luteolin 7-O-glucoside were purchased 
from Sigma-Aldrich (St. Louis, MO). The analytical standard of cynaropicrin was purchased 
from Extrasynthese (Lyon, France). The calibration solutions for HRMS analysis were obtained 
from Thermo Fisher Scientific (Bremen, Germany). The ingredients for the preparation of white-
breads and enriched breads were purchased from a local market. 
3.2.2 Plant material and extraction of bioactive compounds 
Fresh globe artichokes were from the varietal type "Tondo di Paestum". External leaves and 
floral stems were separated from the artichoke heads (including outer bracts, inner bracts and the 
receptacle). The three fractions were washed and freeze-dried and afterwards were minced with a 
Grindomix knife mill (10000 rpm for 30 sec.) until to obtain three different dry powders. The 
extraction of PPs and cynaropicrin from artichoke powders was carried out with a method 
adapted by Palermo et al., (2013) and Menin et al., (2012).55,56 Specifically, 10 mL of a solution 
methanol/water (75:25, v/v) acidified with 0.1% of formic acid were added to 500 mg of dry 
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sample. Ultrasound assisted extraction was performed for 20 minutes. Then, the samples were 
centrifuged 10 min at 4000 rpm at 4°C. Two milliliters of supernatant were collected and further 
ultra-centrifuged 10 min at 14800 rpm at 4°C before the analysis. The identification and 
quantification of PPs and cynaropicrin was carried out using an U-HPLC system coupled to an 
Exactive mass spectrometer (Thermo Fisher Scientific, Bremen, Germany). Santonin was  used 
as internal standard for the evaluation cynaropicrin extraction recovery. 
3.2.3 Total phenols and antioxidant activity of artichoke fractions 
One milliliter of the extracts obtained as reported above was dried under nitrogen flow and 
subsequently was re-suspended in 1 mL of methanol and appropriately diluted before the 
analysis. The amount of total phenols was measured using the Folin–Ciocalteu assay as 
described by Ferracane et al., (2010).57 Specifically, 125 μL of sample properly diluted were 
mixed with 125 μL of Folin–Ciocalteau phenol reagent and allowed to react for 6 min. After 6 
min, 1.25 mL of saturated Na2CO3 solution (7.5%) was added. The samples were incubated for 
90 minutes at room temperature, before that the absorbance of the reaction mixture was 
measured with a spectrophotometer (PG Instruments, UK) set at 760 nm. The results were 
expressed mg of gallic acid equivalents (GAE)/g of dry weight (DW). The antioxidant capacity 
(AC) of the extracts was measured spectrophotometrically by using the DPPH assay according to 
Papillo et al., (2014).58 The results were expressed as µmol Trolox equivalents (TE)/ g of DW. 
3.2.4 Insoluble, soluble and total dietary fiber of artichoke by-products 
The determination of soluble dietary fiber (SDF), insoluble dietary fiber (IDF) and total dietary 
fiber  (TDF) in artichoke dry powders, was carried out according to the protocol described by 
Prosky et al., (1987).59 The results were reported as mg/g of DW. For each sample the IDF/SDF 
ratio was calculated. 
3.2.5 Food preparation 
Three types of artichoke stem powder (ASP) enriched  bread were formulated by using a 
traditional bread recipe and replacing wheat flour with 3%, 6% and 9% of ASP on total 
ingredients. The 3 recipes were reported in Table 3.1.. The ingredients were mixed for 12 min 
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and portions (150 g) of dough were left to rise at room temperature for one hour before baking 
(200°C for 20 min and 185°C for 15 min) in an air ventilated oven. 
Table 3.1. Recipes of ASP-enriched breads and control bread. 
Bread 
Water 
(g) 
Wheat flour 
(g) 
Dry yeast 
(g) 
Salt 
(g) 
Artichoke 
stem powder 
(g) 
Control 50 100 1.2 1 / 
3% ASP 50 95.45 1.2 1 4.55 
6% ASP 50 90.09 1.2 1 9.10 
9% ASP 50 86.3 1.2 1 13.7 
 
3.2.6 In-vitro simulated gastrointestinal digestion 
The gastrointestinal digestion of the ASP-enriched breads was performed by using the method 
described by Minekus et al., (2014) and briefly modified.60 For the oral phase 2.5 g of freeze-
dried sample were minced and mixed for 2 min at 37°C in a thermostatic shaking bath with 1.75 
mL of simulated salivary fluid (SSF), 0.25 mL of α-amylase from porcine pancreas (1500 
U/mL), 12.5 µl of 0.3 M CaCl2 and 488 µl of water. For the simulated gastric phase, oral bolus 
was mixed with 3.75 mL of SGF, 2.5 µl of 0.3 M CaCl2 and 0.8 mL of a solution of porcine 
pepsin (25000 U/mL) made up in simulated gastric fluid (SGF). The pH was adjusted to 3.0 with 
1 M HCl,  the volume was filled up to 10 mL with distilled water and the samples were 
incubated for 2 hours at 37°C in a thermostatic shaking bath.  For the simulated duodenal phase 
(SDP) the gastric chyme was mixed with 5.5 mL of simulated intestinal fluid (SIF), 2.5 mL of 
pancreatin solution (800 U/mL), 1.25 mL of a bile salts solution (10 mM in the final volume), 20 
µl of 0.3 M CaCl2 and 650 µl of distilled water. The pH was adjusted to 7.0 with 1 M NaOH and 
the samples were incubated for 2 hours at 37°C in a thermostatic shaking bath. At the end of 
SDP step, the samples were centrifuged at 4000 rpm for 10 minutes, at 4°C. The soluble 
fractions were separated from the insoluble pellets, and collected for the analysis. The insoluble 
pellets were submitted to a further digestion as previously reported by Colantuono et al., (2016), 
in order to simulate the release of bioactive compounds in the post duodenal phase.61 
Specifically, the residual pellets were added with 15 mL of distilled water and 2.5 mL of Pronase 
E solution (1 mg/mL) and incubated at 37 °C for 1 h (pH 8.0). Subsequently, the samples were 
centrifuged at 4000 rpm for 3 min and the soluble extracts and the pellets were separated. The 
pellets were further added with 17.5 mL of distilled water and 75 µl of Viscozyme L, to obtain 
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the complete disruption of the food matrix, including the DF fraction. The samples were 
incubated at 37 °C for 16 h (pH 4.0) and subsequently the pellets and the soluble fractions were 
separated by centrifugation (4000 rpm for 3 min), before the analysis. For the identification and 
quantification of PPs in the soluble fractions, 500 µL of each soluble extracts, respectively from 
SDP and simulated colon phase (SCP), were dried under nitrogen flow and re-suspended in 1 mL 
of a solution of methanol/water (75:25, v/v) acidified with 0.1% of formic acid, and properly 
diluted before the HRMS analysis. For the identification and quantification of cynaropicrin in the 
extracts from digestion, 200 µL of each soluble extracts from SDP and SCP, were extracted with 
1 mL of ethyl acetate. The samples were mixed for 4 min with a vortex and after 10 min the 
upper fraction was recovered. The procedure was repeated twice for each sample. The three 
supernatants were combined and dried under nitrogen flow. Finally, the samples were re-
suspended in 200 µL of a solution of methanol/water (75:25, v/v) acidified with 0.1% of formic 
acid, before the HRMS analysis. Rosmarinic acid and santonin were used as internal standards 
for assessing the recovery of PPs and cynaropicrin from the digestive extracts, respectively. 
3.2.7 High resolution mass spectrometry (HRMS) analysis 
The method was adapted from Troise et al., (2014) with slight modifications.62 LC-MS data were 
acquired on an Accela U-HPLC system coupled to an Exactive mass spectrometer (Thermo 
Fisher Scientific, San Jose, CA). The Accela system consisted of a quaternary pump, a 
thermostated autosampler (8 °C) and a column oven. Chromatographic separation was carried 
out on a Gemini C18-110Å 5 μm column (150 mm × 2.0 mm) (Phenomenex, Torrance, CA) 
thermostated at 25 °C. Both for PPs and guaianolides analysis, 0.1% formic acid in water 
(solvent A) and 0.1% formic acid in acetonitrile (solvent B) were used. Gradient elution was 
linearly programmed as follows 10% B (1 min), 10–90% B (17 min), constant to 90% B (2 min), 
90–10% B (2 min). The flow rate was set to 200 μL/min and the injection volume was 10 μL. 
The U-HPLC was directly interfaced to an Exactive Orbitrap MS equipped with a heated 
electrospray interface. Mass spectrometer operated in the full spectral acquisition mode, where 
the positive and negative ionization mode was used in the same run in the mass range 
of m/z 150–800. The resolving power was set to 50,000 full width at half-maximum 
(FWHM, m/z 200) resulting in a scan time of 1 s., automatic gain control (AGC), balance (target 
value of 1 106 ), and scan speed, 4 Hz.; maximum injection time was 100 ms. The interface 
parameters were as follows: the spray voltage was + 3.2 kV and − 3.0 kV in positive and 
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negative ion mode, respectively; the tube lens was at 100 V (− 100 V in negative ion), the 
capillary voltage was 30 V (− 50 V in negative ion), the capillary temperature was 275 °C, and a 
sheath and auxiliary gas flow of 30 and 15 arbitrary units were used. Metabolite identification 
was performed by using exact mass values value up to the fifth decimal digit with mass tolerance 
± 5 ppm and in Table 3.2. molecular formula, retention time, theoretical mass, experimental 
mass and error have been reported. Data were evaluated by Xcalibur 3.0 software (Thermo 
Fisher Scientific, Bremen, Germany). 
Table 3.2. High-Resolution Mass Spectrometry Identification of Phenolic Acids,flavonoids and cynaropicrin achieved by Orbitrap 
MS. 
Compound 
Molecular 
formula 
Theoretical Experimental 
Mass accuracy 
(ppm) 
Retention time 
(min) [M-H]- m/z [M+H]+ m/z  
Caffeoylquinic 
acid isomers 
C16H18O9 353.08781  353.08838 1.61 6.28 
Caffeic acid C9H8O4 179.03498  179.03487 -0.61 7.22 
Dicaffeoylquinic 
acid isomers 
C25H24O12 515.11950  515.11938 -0.23 7.3-9.01 
Luteolin 7-O- 
rutinoside 
C27H30O15 593.15119  593.15240 2.04 7.83 
Luteolin 7-O-
glucoside 
C21H20O11 447.09328  447.09399 1.59 8.23 
Luteolin C15H10O6 285.04046  285.04065 0.67 11.08 
Cynaropycrin C19H22O6  347.14891 347.14883 -0.23 10.53 
 
3.2.8 Total Antioxidant Capacity (TAC) 
The total antioxidant capacity (TAC) of the soluble and insoluble fractions from the SDP and 
SCP were measured by the DPPH and DPPH QUENCHER methods, respectively.58 Before the 
analysis the soluble extracts were properly diluted with water and the insoluble pellets were 
freeze-dried. The results were expressed as µmol of TE/g of dry weight (DW). Overall TAC was 
calculated as the sum of the antioxidant capacity of soluble extracts and insoluble pellets from 
the SDP and SCP. 
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3.2.9 α-glucosidase inhibition assay 
The α-glucosidase inhibition assay was carried out as reported by Colantuono et al. (2016), with 
slight modification.61 Specifically, 250 µL of sample from SDP were added to reaction mixture 
instead of 125 µL. Percentage variation of inhibition compared to the control was calculated as 
previously reported.61  
3.2.10 Statistical analysis  
The data were analyzed by ANOVA, and the means were compared by Tukey test (α = 0.05), 
using XLStat statistical software (Addinsoft, New York, NY). All the experiments were 
performed in triplicate. The Pearson product-moment correlation coefficient was used for the 
bivariate correlation analysis among the variables (α = 0.05). 
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3.3 Results  
3.3.1 Characterization of the artichoke by-products 
In Table 3.3. the content of dietary fiber, total PPs and cynaropicrin as well as the antioxidant 
capacity of the artichoke by-products (leaves and stem) in comparison to the head, was reported.  
ASP showed the highest amount of total polyphenols and the highest AA compared to the other 
artichoke fractions. The amount of total phenols in ASP was 1.6 and 3.9 folds higher that the 
amount of total phenols in ALP and AHP, respectively. According to the amount of total 
phenols, the AC was 1.6 and 4.7 folds higher for ASP compared to ALP and AHP, respectively. 
Cynaropicrin abundance was in ALP > ASP > AHP whereas the TDF was in AHP > ALP > 
ASP. In all the fractions the IDF was higher than the SDF but ASP showed the lowest IDF/SDF 
ratio. 
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Table 3.3. Chemical characterization and antioxidant capacity (AC) of the artichoke head and by-products (leaves and stem).Values are expressed as mean ± SD. Values in the 
same column followed by different lower case letters  are significantly different (p < 0.05) according to Tukey’s test. 
 
Artichoke 
parts 
IDF 
(mg/g DW) 
SDF 
(mg/g DW) 
TDF 
(mg/g DW) 
IDF/SDF 
 
AC 
(µmol TE/g of 
DW) 
Total PPs 
(mg GAE/g 
DW) 
Total 
cynaropicrin 
(mg/g DW) 
Head 429.2 ± 12.5 a 182.0 ± 1.8 a 611.2 ± 12.1 a 2.4 31.6 ± 1.7 c 8.8 ± 0.6  c 0.014 ± 0.002 c 
Leaves 363.6 ± 35.5 b 105.2 ± 13.6 c 468.8 ± 49.1 b 3.5 91.1 ± 5.6 b 21.6 ± 2.1 b 20.8 ± 0.5 a 
Stem 251.1 ± 22.4 c 141.9 ± 9.0 b 393.0 ± 20.0b 1.8 147.7 ± 12.6 a 34.7 ± 1.1  a 2.7 ± 0.2 b 
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3.3.2 Bioaccessibility of PPs and cynaropicrin from ASP-enriched breads 
Table 3.4. summarized the data about PPs bioaccessibility. Data  showed that ~97% of 
bioaccessible PPs from all ASP-enriched breads were phenolic acids. DCQA isomers were the 
most abundant compounds released in the SDP followed by CQA isomers and luteolin 7-
rutinoside, the relative abundance being averagely ~61% for DCQA isomers, ~36% for CQA 
isomers, and ~2% for luteolin-7-rutinoside. About the 18% of totally bioaccessible PPs were 
released in the SCP except caffeic acid that was released at the 88%. Data about the 
bioaccessibility of cynaropicrin were reported in Figure 3.1.. It shows that the bioaccessible 
cynaropicrin both in the duodenum and in the colon phase linearly increased with the ASP added 
in the bread. Seventy four percent of totally bioaccessible cynaropicrin was released in the SDP . 
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Table 3.4. Concentrations (µg per g) of polyphenols released upon in vitro digestion of ASP-enriched breads. Values are expressed as mean ± SD. For each compound, different 
lower case letters indicate significantly different values (p < 0.05) according to Tukey’s test. 
Compound 
3% SDP 
(µg/g DW) 
3% SCP 
(µg/g DW) 
Total 3% 
(µg/g DW) 
6% SDP 
(µg/g DW) 
6% SCP 
(µg/g DW) 
Total 6% 
(µg/g DW) 
9% SDP 
(µg/g DW) 
9% SCP 
(µg/g DW) 
Total 9% 
(µg/g DW) 
CQA isomers 244.4 ± 3.2c 31.4 ± 2.3 f 275.8 ± 5.1 496.4 ± 11.5 b  95.0 ± 8.1 e 591.5 ± 12.1 674.5 ± 22.9 a 138.9 ± 15.6 d 813.4 ± 25.0 
DCQA isomers 379.1 ± 14.3c 44.7 ± 2.2 f 423.8 ± 16.2 876.2 ± 16.9 b 152.2 ± 8.0 e 1028.4 ± 18.1 1218.2 ± 39.0 a 257.0 ± 23.3 d 1475.2 ± 48.4 
Caffeic acid* 5.1 ± 0.4 d 40.4 ± 1.3 c 45.5 ± 0.2 11.0 ± 0.3 d 65.5 ± 9.6 b 76.4 ± 9.5 14.1 ± 1.4 d 111.5 ± 8.3 a 125.6 ± 8.3 
Phenolic acids 628.6 ± 17.7 c 116.5 ± 2.6 f 745.1 ± 19.9 1383.6 ± 23.8 b 312.7 ± 25.1 e 1696.3 ± 31.7 1906.8 ± 17.6 a 507.4 ± 36.6 d 2414.2 ± 42.3 
Luteolin 7-Rut.** 12.0 ± 0.2 c 2.0 ± 0.1 f 14.0 ± 0.2 23.5 ± 0.5 b 3.6 ± 0.1 e 27.1 ± 0.4 32.6 ± 0.8 a 5.0 ± 0.8 d 37.7 ± 0.9 
Luteolin 7-Glu. 1.4 ± 0.0 c 0.8 ± 0.0 d 2.2 ± 0.0 2.5 ± 0.2 b 1.6 ± 0.1 c 4.0 ± 0.3 4.0 ± 0.3 a 2.4 ± 0.2 b 6.4 ± 0.4 
Luteolin 7.3 ± 0.3 c 2.2 ± 0.1 f 9.4 ± 0.3 13.4 ± 0.5 b 3.9 ± 0.2 c 17.3 ± 0.7 15.2 ± 1.3 a 5.7 ± 0.8 d 20.9 ± 1.6 
Flavonoids 20.7 ± 0.5 c 4.9 ± 0.1 f 25.6 ± 0.5 39.4 ± 0.7 b 9.1 ± 0.4 c 48.5 ± 1.0 51.8 ± 2.2 a 13.1 ± 1.8 d 64.9 ± 2.8 
Total PPs 649.3 ± 18.1 c 121.3 ± 2.6 f 770.6 ± 20.2 1423.0 ± 24.2 b 321.8 ± 25.5 c 1744.8 ± 32.5 1958.6 ± 16.2 a 520.5 ± 38.1 d 2479.1 ± 43.9 
*Expressed as µg of chlorogenic acid equivalents;**Expressed as µg of luteolin-7-Glu equivalents; 
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Figure 3.1. Cynaropicrin concentrations (µg/g of dry bread)  in the simulated duodenal phase (SDP) and simulated 
colon phase (SCP). Values are expressed as mean ± SD. Different lower case letters indicate values significantly 
different (p < 0.05) according to Tukey’s test. 
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3.3.3 Overall Total Antioxidant Capacity (TAC) upon digestion 
The overall TAC of the ASP-enriched breads and the contribution of the soluble and of the 
unsoluble fraction at the duodenum and colon steps were graphically shown in Figure 3.2.. Data 
showed a similar repartition of the antioxidant activity among the evaluated steps for all the 
breads. As expected a significant correlation between the antioxidant capacity of the soluble 
extracts from the SDP and SCP and the concentrations of total PPs released under the same 
digestive steps (r = 0.992; p < 0.0001) was found.  
 
Figure 3.2. Overall TAC released in the intestinal steps upon in vitro digestion of ASP-enriched breads. Mean 
values are expressed as µmol of TE/g of dry bread. Data were corrected for the antioxidant activity of control bread. 
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3.3.4 Inhibition of α-glucosidase 
The results were reported in Figure 3.3.. Data showed that 0.121 mg, 0.269 mg and 0.384 mg of 
total PPs released in the SDP extracts, from 3%, 6% and 9% ASP-enriched breads, were able to 
inhibit by 6.7%, 10.6% and 16.9% 1 U of α-glucosidase, respectively. A significant correlation 
between the amount of total PPs released in the SDP extracts and the α-glucosidase inhibition 
rate (r = 0.952; p = 0.003) was found. 
 
Figure 3.3. Enzyme inhibition rate of extracts from SDP. Data were corrected for the inhibition elicited by control 
bread. Different lower case letters indicate values significantly different (p < 0.05) according to Tukey’s test.
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3.4 Discussion 
In this study the artichoke stem was used as food ingredient in bread formulation  and  the 
bioaccessibility of PPs and cynaropicrin, the overall TAC and the ability of breads to inhibit α-
glucosidase in the intestinal tract were tested in vitro. 
The artichoke stem was selected as possible functional ingredient between the artichoke by-
products for its DF and PPs content. Data showed that ASP had a higher amount of total PPs, 
mainly including phenolic acids, and TAC as well as a more balanced IDF/SDF ratio than the 
artichoke leaves. These findings confirmed previous literature.4,6,7,45 Moreover, the composition 
of the DF was particularly interesting because an IDF/SDF ratio ranging from 1 to 2.3 is 
considered the best to get the health benefits associated to DF consumption.63 On the contrary 
the artichoke leaves possessed the highest amount of the bitter sesquiterpene cynaropicrin, as 
previously reported by Eljounaidi et al., (2015).64 
Bioaccessibility data and the antioxidant capacity of the extracts solubilized along the intestinal 
tract in vitro, showed that the amount of PPs and the antioxidant activity released from the ASP-
enriched breads correlated with the amount of ASP used in the bread formulation. 
Despite the highest amount of PPs from the breads were released in the duodenal step, a part of 
PPs ranging between 16% and 21% of totally bioaccessible compounds, was released in the 
colon step of digestion following the enzyme action of Pronase E and Viscozyme L (including 
arabanase, cellulase, β-glucanase, hemicellulase, and xylanase) on the undigested material from 
the duodenum step. Interestingly, the compound mostly released in SCP was the caffeic acid 
accounting for the 25% of total PPs bioaccessible in the SCP. This finding could be explained by 
the breakdown of the linkages between caffeic acid and the IDF of ASP following the action of 
the cell wall degrading enzymes on the pellets from the SDP, similarly to what was previously 
reported for unripe apples, winemaking by-products, highland barley and quinoa seeds.65-68 On 
the other hand caffeic acid might result also from the hydrolysis of chlorogenic acid due, in our 
system, to the side esterase activity of Pronase E,69-71 simulating the activity of microbial 
esterases in vivo.72-75 From a physiological point of view the potential delivery of caffeic acid in 
the colon is worth of notice because caffeic acid has a stronger antioxidant capacity and is more 
easily absorbed from the colon than chlorogenic acid.76-78 
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The potential antioxidant activity along the GiT found in this study was in accordance to 
previous in vitro and in vivo evidence showing that artichoke indigestible fraction may affect in a 
positive way the intestinal health by modulating bacterial enzymatic activities and antioxidant 
status of rat cecum.18,53 Interestingly the increase of soluble TAC occurred also in the colon step 
and went in parallel with a ~5 fold-reduction of the antioxidant capacity of the insoluble pellets 
from SDP. This finding was in accordance to Mrabet et al., (2017) and suggested that a further 
destroying of the food matrix as obtained by the enzyme activity of Viscozyme L may act in vivo 
through microbiota action and modification.79 
The bitter sesquiterpene cynaropicrin was also found to be released in the duodenum and colon 
steps in amount that was proportional to the ASP added in the bread. However, considering  the 
amount of this compound in the ASP, it was calculated that the total amount retrieved upon 
digestion was meanly about 2% of the amount present in the breads. It was hypothesized that 
cynaropicrin was mainly degraded by the simulated physiological conditions, or it was not 
effectively extracted by the aqueous digestive fluids as already reported by Thormann et al., 
(2014) for the sesquiterpene lactone nobilin.80 Appropriate studies are needed to clarify the 
mechanisms behind this result in order to potentiate the bioaccessibility of this compound. In 
fact, cynaropicrin presence in the GiT may have a functional role because it possesses a wide 
range of pharmacological properties that may work from the intestine (such as anti-
hyperlipidemic, anti-trypanosomal, anti-malarial, antifeedant, antispasmodic, anti-photoaging, 
and anti-tumor action), also through  activation of bitter sensory receptors.81 
Finally, this study also demonstrated that the PPs-rich extracts resulting from the digestion of 
ASP-enriched breads exerted a inhibitory activity towards α-glucosidase that was proportional to 
the amount of ASP in the breads. It was calculated that the ratio between the amount of total PPs 
in the tested extracts and 1 unit (U) of enzyme was equal to 0.121 mg/1 U, 0.269 mg/1 U and 
0.384 mg/1 U, for the α-glucosidase inhibition rate found for the 3%, 6% and 9% ASP-enriched 
bread, respectively. On the other hand, in a previous paper, it was calculated that 0.007 mg of 
PPs in the extract resulting from the SDP of a 7.5% pomegranate peels-enriched cookies in vitro 
digestion inhibited the activity of 1 U of α-glucosidase by 84%, thus indicating that pomegrante 
PPs, mainly including ellagitannins and ellagic acid, are stronger natural inhibitor of this 
enzyme.61 These findings were in accordance with the evidence that the specific chemical 
structure of PPs influence the α-glucosidase inhibition. Generally, a high numbers of galloyl and 
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hydroxyl groups in the molecular structure increase the enzyme inhibitory capacity of PPs while 
hydrogenation and glycosylation work in a opposite way.15,82-84 Despite the use of α-glucosidase 
from Saccharomyces cerevisiae could be considered as a limitation of this study, because it is 
known that the extent of activity of α-glucosidase inhibitors may vary according to the origin of 
α-glucosidase,85 previous evidence demonstrated in vivo that artichoke products have effective 
hypoglygemic effect.29,31,33,86,87 That effect was correlated to the phenolic fraction, mainly 
including CQA, DCQA and flavonoids well known inhibitors of mammalian α-glucosidases.15,88, 
89 Intestinal α-glucosidase is located in the brush-border surface membrane of the intestinal cells 
and it is a key enzyme for the conversion of oligosaccharides and disaccharides, into absorbable 
monosaccharides. The inhibition of this enzyme leads to the modulation of glucose absorption in 
the small intestine, and therefore the postprandial blood glucose level and the related neuro-
hormonal response. Controlling the blood glucose level is considered an effective way to prevent 
diabetes and obesity exacerbation.90,91 
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3.5 Conclusion 
In conclusion, in this study an artichoke stem powder was used as ingredient for the formulation 
of new breads. Data showed that the potential release of PPs and cynaropicrin as well as the 
antioxidant activity and α-glucosidase activity in the small intestine were proportional to the 
amount of ASP added to the bread recipe. Interestingly, a part of these bioactive compounds are 
potentially released in the colon thus suggesting an effect of the new foods that may be mediated 
by the intestinal microbiota. 
Further studies are needed to assess the biological effects of ASP-enriched breads in vivo as well 
as the specific role of the microbiota. 
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3.6 Abbreviations 
AC: Antioxidant capacity; 
AHP: Artichoke head powder 
ALP: Artichoke leaves powder; 
ASP: Artichoke stem powder; 
CQA: Caffeoylquinic acids; 
DCQA: di-caffeoylquinic acids; 
DF: Dietary fiber 
GAE: Gallic acid equivalents; 
GiT: Gastrintestinal tract; 
IDF: Insoluble dietary fiber; 
PPs: Polyphenols  
SCP: Simulated colon phase; 
SDF: Soluble dietary fiber; 
SDP: Simulated duodenal phase; 
SGF: Simulated gastric fluid; 
SIF: Simulated intestinal fluid; 
SSF: Simulated salivary fluid; 
TAC: Total antioxidant capacity; 
TDF: Total dietary fiber; 
TE: Trolox equivalents; 
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Abstract 
Polyphenols (PPs) and dietary fibers (DF) are food components with well known health 
benefits. A novel ingredient based on starch-alginate microspheres (MS), working in vivo as 
DF, was recently developed. 
The main objectives of this work were to develop new antioxidant DF and to assess their 
potential functionality.  
Three types of antioxidant MS were obtained by inclusion of pomegranate peels (PPe), olive 
leaves (OLe) and artichoke leaves (ALe) extracts at 20% (w/w) in the formulation of the basic 
MS. The physico-chemical properties of the new MS were compared with those of 6 
commercially available DF concentrates and with wheat and oat bran. In order to evaluate the 
potential efficacy to release PPs along the gastrointestinal tract (GiT), PPe-microspheres 
(PPe-MS) were submitted to an in vitro simulated gastrointestinal digestion.  
Data showed that the three types of MS exerted higher free antioxidant capacity (free-AC) 
than commercial DF rich products, and the bound antioxidant capacity (bound-AC) of PPe-
MS was even comparable to that of wheat bran and 4.4 folds higher than that of oat-bran. The 
release of ellagitannins (ETs) along the GiT decreased from the salivary up to the small 
intestine phase whereas gallic acid, ellagic acid (EA) and its derivatives had an opposite trend. 
However, a residual amount of PPs was found in the pellet obtained from the small intestine 
step of the digestion. This finding suggested that in vivo a part of ETs and EA may reach the 
colon, and may be transformed by the local microbiota in biologically active urolithins. 
In conclusion, in this study three types of antioxidant DF constituted by PPs extracted from 
three common plant by-products, and included in starch-alginate based MS, were developed. 
Further studies are warrented to asses the impact of the MS in food formulation and to 
evaluate in vivo the antioxidant efficacy and the impact on health. 
Keywords: antioxidant dietary fiber, functional ingredients, plant by-products, polyphenols, 
starch-based microspheres 
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4.1. Introduction 
Polyphenols (PPs) and dietary fibers (DF) are two classes of food components well known for 
their beneficial effects on human health.  
PPs are secondary metabolites of plants and represent the most abundant antioxidant 
compounds in foods.1,2 Whole grains, fruits and vegetables are the major dietary sources of 
PPs.3 Several in vitro and in vivo studies support the role of PPs in the prevention of non 
communicable chronic diseases and obesity.4-9 Even though certain systemic health effects of 
PPs are correlated to the extent of their absorption along the gastrointestinal tract (GiT) and 
post-absorptive metabolism,2,10 the gastrointestinal mucosa is the primary site for the 
beneficial effects associated to these phytochemicals, since it is directly exposed to them after 
their release from the food matrix.11,12 In the intestinal lumen, PPs exert antioxidant and anti-
inflammatory activity, thus counteracting the local subclinical oxidative stress and 
inflammation. Furthermore, PPs may affect the activity of key digestive enzymes, influencing 
the bioavailability and the metabolism of carbohydrates and fats.13-19 For these reasons, 
several technological strategies were developed, aiming to obtain new functional foods and 
ingredients for the targeted delivery of PPs along the GiT.20,21 In fruits, vegetables and whole 
grains, PPs occur in free form (mainly as glycosides) or covalently bound to cell wall 
structural components.22 Additionally, PPs may be found physically entrapped or linked to 
food macronutrients (i.e. starch, proteins and lipids) mainly through non-covalent 
interactions.23,24 Free and non-covalently bound PPs may be delivered in the upper GiT by 
direct solubilization in the intestinal fluids or after the action of digestive enzymes on food 
matrix. Conversely, PPs covalently bound to DF pass unmodified through the upper intestine 
and reach the colon. In this site, bound PPs are delivered by the action of microbial enzymes, 
thus creating a reducing environment and being available for absorption in their original 
chemical forms or as microbial metabolites.25-28 In the large intestine, PPs may also positively 
change the composition of the microbiota and, in turn, the host physiology.29-31 
So from a physiological perspective plant foods having PPs bound to DF can be considered as 
natural carriers of PPs along the GiT. That the reduced risk of several non communicable-
chronic diseases found by epidemiological studies associated to a regular consumption of 
fruits and vegetables and whole grains are due to their content of both DF and micronutrients 
(including PPs and minerals) is actually well known.32 As a consequence for general 
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population a minimum daily intake of 25 g/day of DF was recommended by the European 
Food Safety Authority (EFSA), Food and Agriculture Organization of the United Nations 
(FAO) and World Health Organization (WHO)33 and the development and marketing of 
functional foods enriched with PPs and DF is always a hot topic for food scientists and 
industry.34-37 In this perspective the recent inclusion, by the CODEX Alimentarius 
Commission, among the definitions of DF of “synthetic carbohydrate polymers showing 
health benefits” along with the classical definitions of “edible carbohydrate polymers 
naturally occurring in foods” and “carbohydrate polymers, obtained from raw foods by 
physiological, enzymatic or chemical means and showing health benefits” opened new 
opportunities in the field of functional ingredient development.33,38 
In this frame, Rose et al. (2009) developed a new source of DF, named starch-entrapped 
microspheres (MS), constituted by electrostatically cross-linked alginate matrix forming a 
web-like structure that is filled with native corn starch. The entrapped corn starch may 
partially escape the digestion in the small intestine thereby potentially acting like resistant 
starch in the colon. Compared to other DF, including corn bran arabinoxylans and long-chain 
β-glucans, the starch-entrapped MS showed a beneficial fermentation profile, inhibiting the 
growth of potentially harmful bacteria and increasing short-chain fatty acids (SCFAs) 
production during an in vitro faecal fermentation.39-41 This innovative source of DF was 
recently patented by Hamaker and coworkers.42 Furthermore, corn native starch was 
previously reported as an effective filling agent of calcium alginate matrix, able to enhance 
the entrapment capacity of probiotic bacteria, PPs and other bioactive chemical compounds.43-
50 Some plant by-products from agricultural and food industry are rich and cheap sources of 
PPs and DF. These materials can be dehydrated and submitted to solvent extraction for the 
recovery of PPs-rich extracts, or directly used in their whole form as functional ingredients for 
the formulation of new foods.51-56 
In this framework, the main objective of this study was to develop new antioxidant DF-
ingredients by using agricultural by-products as natural sources of PPs. For this purpose,three 
PPs-rich extracts were obtained from pomegranate peels (PPe), olive leaves (OLe) and 
artichoke leaves (ALe), and were used as a functional filling for the development of new 
starch-alginate based MS. The physico-chemical properties of the new ingredients were 
compared to those of 6 commercially available DF concentrates, as well as to wheat bran and 
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oat bran. PPe-microspheres (PPe-MS) were submitted to an in vitro simulated gastrointestinal 
digestion in order to evaluate their potential efficacy to deliver PPs and to exert antioxidant 
activity along the GiT. 
4.2. Materials and Methods 
4.2.1. Chemicals 
HPLC-grade methanol, acetonitrile and water were purchased from Merck (Darmstadt, 
Germany). Ethanol, formic acid, ethyl acetate and acetone were obtained from VWR 
international (Fontenay-sous-Bois, France). Total DF assay kit was purchased from 
Megazyme International (Wicklow, Ireland). Calcium chloride, celite, hydrochloridric acid 
(HCl), 4-morpholineethanesulfonic acid (MES), 2,2-diphenyl-1-picrylhydrazyl, 95% (DPPH), 
tris(hydroxymethyl)aminomethane hydrochloride (Tris-HCl), sodium alginate, sodium 
hydroxide and 6-hydroxy-2, 5, 7, 8-tetramethylchromane-2-carboxylic acid were purchased 
from Sigma-Aldrich (St. Louis, MO). Standards of punicalagin, ellagic acid (EA), gallic acid 
(GA), oleuropein, chlorogenic acid, caffeic acid, cynarin, ferulic acid, p-cumaric acid, rutin, 
apigenin, hydroxytyrosol, luteolin and protocatechuic acid were purchased from Sigma-
Aldrich (St. Louis, MO). The standard of cynaropicrin was obtained from Extrasynthese 
(Lyon, France). The standard of luteolin-4-O-glucoside was obtained from Indofine Chemical 
Company (Somerville, NJ). Corn starch was obtained from Tate & Lyle (Decatur, IL). PPe 
powder was obtained from Detrade UG (Bremen, Germany). Organic wheat bran and oat bran 
(Fior di loto, Orbassano, Italy) were purchased in a local market. A barley β-glucans 
concentrate (Glucagel) was obtained from DKSH (Miribel Cedex, France). Potato DF, pea 
cortical DF, citrus DF, carrot DF, bamboo DF were purchased from ITALI (Reggio Emilia, 
Italy). ALe and OLe dry powder were purchased in a local herbalist's shop. 
4.2.2. Preparation of plant by-products extracts 
PPe extract: One liter of a solution water/ethanol, (50:50, v/v) with 0.5% formic acid was 
added to 250 g of PPe powder. The mixture was sonicated for 30 min and subsequently 
filtered through a filter paper (VWR international, qualitative filter paper 600). The filtered 
extract (590 mL) was recovered and concentrated under vacuum in a rotary evaporator (T < 
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30°C); the residual acqueous fraction was finally freeze-dried. Prior to the preparation of PPe-
MS, the dry extract was solubilized in 590 mL of distilled water. 
OLe extract: One liter of a solution ethanol/water (70:30, v/v) was added to 250 g of OLe 
powder. The mixture was sonicated for 30 min and subsequently filtered through a filter paper 
(VWR international, qualitative filter paper 600). The filtered extract (490 mL) was recovered 
and concentrated under vacuum in a rotary evaporator (T < 30°C); the residual acqueous 
fraction was finally freeze-dried. Prior to the preparation process of OLe-microspheres (OLe-
MS), the dry extract has been solubilized in 490 mL of distilled water. 
ALe extract: One liter of a solution ethanol/water (75:25, v/v) with 0.1% formic acid was 
added to 250 g of ALe powder. The mixture was sonicated for 30 min and subsequently 
filtered through a filter paper (VWR international, qualitative filter paper 600). The filtered 
extract (1149 mL) was recovered and concentrated under vacuum in a rotary evaporator (T < 
30°C); the residual acqueous fraction was finally freeze-dried. Prior to the preparation process 
of ALe-microspheres (ALe-MS), the dry extract was dissolved in 670 mL of distilled water.  
4.2.3. Preparation of functional starch-based MS 
Starch-alginate based MS were prepared following a protocol previously described by Rose et 
al., (2009).39 Briefly, three different suspensions were obtained by mixing at room 
temperature distilled water, native corn starch, sodium alginate and the acqueous extracts 
from PPe, ALe and OLe, respectively. The suspensions were prepared including the extracts 
at 20% (w/w) in the formulation of the basic MS constituted by distilled water/native corn 
starch/sodium alginate (69:9:2, w/w/w). 
With continuous stirring, each suspension was pumped by a peristaltic pump through a 22 
gauge needle (EFD, Nordon Company) into a solution of calcium chloride (4% w/v). 
Hydrogel MS were kept in the calcium chloride solution for 1 h, before harvesting and 
washing with distilled water. Subsequently, the MS were dried in an oven at 38 ± 2 °C for 24 
h. Control-MS were prepared mixing distilled water, native corn starch and sodium alginate 
(89:9:2, w/w/w). Before the analysis, the dry MS were powdered with a Grindomix knife mill 
(10000 rpm for 30 s). 
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4.2.4. Determination of insoluble, soluble and total dietary fiber 
The amount of soluble dietary fiber (SDF), insoluble dietary fiber (IDF) and total dietary fiber 
(TDF) was determined according to the gravimetric enzymatic method as described by Prosky 
et al., (1987).57 For each sample the IDF/SDF ratio was calculated.  
4.2.5. Water holding capacity, water solubility and oil holding capacity  
The water holding capacity (WHC) was determined using the method described by Fuentes-
Alventosa et al., (2009) slightly modified.58 Briefly, 200 mg of sample were placed in a 50 
mL centrifuge tube and mixed with 12 mL of distilled water. After 24 h of stirring at room 
temperature, the suspension was centrifuged at 4000 rpm for 45 min. Then, the supernatant 
was carefully removed, and the wet pellet was weighed. WHC was calculated as mL of water 
per gram of sample. For the determination of the water-solubility, the wet pellet resulting 
from the WHC analysis, was freeze-dried and weighed. The water-solubility was calculated 
considering the weight difference between the weights of the residual pellet and of the initial 
sample. The results were expressed as a percentage of solubilized sample. 
The oil holding capacity (OHC) was determined using the method described by Fuentes-
Alventosa et al., (2009) slighty modified.58 200 mg of each sample were suspended in 12 mL 
of sunflower seeds oil. After 24 h of stirring at room temperature, the suspension was 
centrifuged at 4000 rpm for 45 min. The supernatant was carefully removed, and the oil-
imbibed pelletwas weighed. OHC was expressed as mL of sunflower seeds oil per gram of 
sample. The analyses were performed in triplicate. 
4.2.6. Antioxidant characterization of DF and MS products  
4.2.6.1. Extraction of free and bound antioxidant compounds 
The hydroalcoholic extraction and the alkaline hydrolysis of samples was performed as 
reported by Papillo et al., (2014) with slight modifications.59 For all the samples, free 
antioxidant compounds were extracted with 4 mL of a solution methanol/water (70:30, v/v) 
added to 100 mg of sample. Then the mixture was sonicated for 30min using an ultrasound 
bath. Then, the samples were centrifuged at 4000 rpm for 10 min at 4°C, and the supernatants 
were recovered for the analysis. The resulting pellet was hydrolyzed by adding 2 mL of 4 M 
NaOH in agitation for 2 h. After the alkaline hydrolysis the pH of each sample was adjusted 
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to 2.0 with 6 M HCl. Subsequently, the samples were centrifuged at 4000 rpm for 10 min and 
the supernatants were recovered and extracted three times with 15 mL (5 mL for 3 times) of 
ethyl-acetate. The combined extracts were dried under nitrogen flow and re-suspended in 1 
mL of methanol/water (70:30, v/v) prior to perform the analysis. 
4.2.6.2. Free and bound antioxidant capacity of MS and DF products 
For all the samples, the antioxidant capacity of free polyphenols (free-AC) and the antioxidant 
capacity of bound polyphenols (bound-AC) were evaluated by using the DPPH method 
according to Papillo et al. (2014).59 
Briefly, a DPPH solution was prepared by diluting 0.01 mmol of DPPH in 10 mL of pure 
methanol and adjusting the absorbance of the DPPH radical solution to 0.9 ± 0.02 at 517 nm. 
Two hundred microliters of sample were added to 1 mL of DPPH solution, and after 10 min, 
the absorbance was measured with a spectrophotometer (PG Instruments, UK) set at 517 nm. 
Free-AC and Bound-AC values for PPe-MS, OLe-MS and ALe-MS were obtained by 
deduction of those obtained for the control MS. Data were reported as µmol Trolox equivalent 
(TE)/100g of product. The overall total antioxidant capacity (TAC) of the products was 
calculated as the sum of free-AC and bound-AC. 
4.2.7. High Resolution Mass Spectrometry (HRMS) analysis of free and bound PPs in 
MS 
The hydroalcoholic extracts and the the extracts from alkaline hydrolysis were analyzed for 
the determination of free and bound PPs in PPe-MS, ALe-MS and OLe-MS. LC-MS data 
were acquired on an Accela U-HPLC system coupled to an Exactive Orbitrap mass 
spectrometer (Thermo Fisher Scientific, San Jose, CA). The Accela system consisted of a 
quaternary pump, a thermostated autosampler (10 °C) and a column oven. Chromatographic 
separation was carried out on a Gemini C18-110A 5 μm column, 150 mm x 2.0 mm 
(Phenomenex, Torrance, CA) heated to 30°C. The mobile phase consisted of 0.1% formic 
acid water (A) and 0.1% formic acid acetonitrile (B), the flow rate was set to 200 μL/min and 
the injection volume was 10 μL.  
For the analysis of PPs from PPe-MS, the extracts were dried under nitrogen flow and 
resuspended in a solution methanol/water (50:50, v/v). The gradient elution was as follows: 0 
% B (1 min), 0–10 % B (1-2.5) min, 10–30 % B (2.5-7.5 min), 30-40 % B (7.5-9) min, 40-70 
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% B (9-10) min, 70-98 % B (10-11.5) min, constant at 98% B (11.5-13) min, 98-0 % B (13-
16) min. For PPs and cynaropycrin from ALe-MS analysis, the gradient elution was as 
follows: 10 % B (1 min), 10-90 %B (1-18) min, constant at 90 % B (18-20) min, 90-10% B 
(20-22) min. For OLe-MS PPs analysis, the gradient elution was as follows: 10% B (1 min), 
10-90% B (1-8) min, constant to 90% B (8-10) min, 90-10% B (10-12 min). 
The U-HPLC was directly interfaced to an Exactive Orbitrap MS equipped with a heated 
electrospray interface (HESI). Acquisition was performed in both positive and negative 
ionization modes, in the mass range of m/z 100–1300. The resolving power was set to 50,000 
full width at half-maximum (FWHM, m/z 200) resulting in a scan time of 1 s. The automatic 
gain control was used in balanced mode (1 × 106 ions); maximum injection time was 100 ms. 
The interface parameters were as follows: spray voltage was at 3.0 kV (positive mode and 
negative mode) for artichoke and olive and 3500 kV for pomegranate analysis, capillary 
voltage 50V, capillary temperature at 275 °C, sheath gas at 35 arbitrary units, and auxiliary 
gas at 15 arbitrary units. The instrument was externally calibrated by infusion with two 
different calibration solutions: for positive ion calibration mode, the solution consisted in 
caffeine, Met–Arg–Phe– Ala (MRFA), Ultramark 1621, and acetic acid in a mixture of 
acetonitrile/methanol/water (2:1:1, v/v/v); instead the negative ion mode calibration solution 
consisted in sodium dodecyl sulfate, sodium taurocholate, and Ultramark 1621 in 
acetonitrile/methanol/water solution (2:1:1, v/v/v) containing 1% acetic acid.  
Chromatographic data acquisition and peak integration were performed using Xcalibur 
software (Thermo Fisher Scientific, San Jose, USA). Calibrations curves of punicalagin, EA, 
GA, oleuropein, chlorogenic acid, caffeic acid, cynarin, ferulic acid, p-coumaric acid, rutin, 
apigenin, hydroxytyrosol, luteolin, protocatechuic acid, luteolin-4-O-glucoside and 
cynaropicrin were constructed in the linearity range 100-5000 ng/mL. Metabolite 
identification was performed by using exact mass values value up to the fifth decimal digit 
with mass tolerance ± 5 ppm and in Table 4.1. molecular formula, retention time, theoretical 
mass, experimental mass and error have been reported. 
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Table 4.1. High-Resolution Mass Spectrometry Identification of bioactive compounds achieved by Orbitrap MS. 
Compound 
Molecular 
formula 
Theoretical Experimental Mass accuracy 
(ppm) 
Retention time 
(min) [M-H]- m/z [M+H]+ m/z  
PPe-MS 
Punicalin C34H22O22 781.05300  781.05389 1.14 6.3-6.7 
Punicalagin C48H28O30 1083.05926  1083.05994 0.63 7.6-7.9 
Causarinin C41H28O26 935.07960  935.08118 1.69 8.2 
Galloyl-HHDP-hexoside C27H22O18 633.07334  633.07410 1.20 8.6 
Granatin B C41H28O27 951.07452  951.07556 1.09 9.2 
Ellagic acid hexoside C20H16O13 463.05181  463.05225 0.95 8.7 
Ellagic acid pentoside C19H14O12 433.04125  433.04135 0.23 9.6 
Ellagic acid deoxyhexoside C20H16O12 447.05690  447.05701 0.25 9.7 
Ellagic acid C14H6O8 300.99899  300.99915 0.53 10.4 
Gallic acid C7H6O5 169.01425  169.01378 -2.78 6.4 
OLe-MS 
Protocatechuic acid C7H6O4 153.01933  153.01865 -4.44 4.7 
Verbascoside C29H36O15 623.19814  623.19818 0.06 6.1 
p-coumaric acid C9H8O3 163.04007  163.03964 -2.64 6.6 
Ferulic acid C10H10O4 193.05063  193.05042 -1.09 6.74 
Luteolin rutinoside C27H30O15 593.15119  593.15149 0.51 6.05 
Rutin C27H30O16 609.14611  609.14575 -0.59 6.07 
Apigenin rutinoside C27H30O14 577.15628  577.15643 0.26 6.31 
Luteolin glucoside C21H20O11 447.09328  447.09222 -2.37 6.57 
Apigenin glucoside C21H20O10 431.09837  431.09863 0.60 6.55 
Hydroxytyrosol C8H10O3 153.05572  153.05499 -4.77 4.12 
3,4-DHPEA-AC C10H12O4  197.08084 197.08118 1.73 5.29 
Elenolic acid C11H14O6  243.08631 243.08647 0.66 5.81 
p-HPEA-EA C19H22O7  363.14383 363.14392 0.25 6.54 
Oleuropein C25H32O13  541.19157 541.19159 0.04 6.68 
Ligstroside C25H32O12  525.19665 525.19647 -0.34 7.13 
methyl- DHPEA-EA C20H24O8  393.15439 393.15427 -0.31 7.17 
ALe-MS 
Caffeoylquinic acid isomers C16H18O9 353.08781  353.08835 1.53 6.28 
Caffeic acid C9H8O4 179.03498  179.0345 -2.68 7.22 
Dicaffeoylquinic acid 
isomers 
C25H24O12 515.11950  515.11816 -2.60 7.3-9.01 
Luteolin 7-O- rutinoside C27H30O15 593.15119  593.15094 -0.42 7.83 
Luteolin 7-O-glucoside C21H20O11 447.09328  447.09207 -2.71 8.23 
Luteolin 7-O-glucuronide C21H18O12 461.07255  461.07205 -1.08 8.53 
Apigenin 7-O-glucoside C21H20O10 431.09837  431.09766 -1.65 8.93 
Luteolin 7-O-malonyl-gluco. C24H22O14 533.09368  533.09497 2.42 9.06 
Apigenin 7-O-glucuronide C21H18O11 445.07882  445.07748 -3.01 9.29 
Luteolin C15H10O6 285.04046  285.04105 2.07 11.08 
Apigenin C15H10O5 269.04555  269.04596 1.52 12.26 
Cynaropycrin C19H22O6  347.14891 347.14886 -0.14 10.53 
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4.2.8. In vitro gastrointestinal digestion of PPe-MS  
Before the in vitro gastrointestinal digestion, 2.5 g of PPe-MS and control-MS were cooked at 
100°C for 20 min in 25 mL of distilled water as reported by Venkatachalam et al..60 5 g of 
cooked PPe-MS and control-MS were submitted to the in vitro gastrointestinal digestion as 
reported by Minekus et al., (2014) with slight modifications.61 Specifically, α-amylase from 
porcine pancreas and the simulated intestinal fluid (SIF) weres used in the oral phase and in 
the intestinal phase in substitution of salivary α-amylase and bile salts, respectively. At each 
digestive step an aliquot of sample was withdrawn and analyzed by HRMS as described 
above for PPs from PPe-MS. The pellet obtained after the simulated intestinal phase (SIP) 
was hydrolyzed with 15 mL of 4 M NaOH in agitation for 2 h. After adjusting  to pH 2.0 with 
6 M HCl, the sample was centrifuged at 4000 rpm for 10 min and the supernatant was 
recovered and extracted for 4 times with 20mL of ethyl-acetate. The combined extracts were 
dried under vacuum and re-suspended in 2 mL of a solution methanol/water (50:50, v/v) 
immediately prior to the HRMS analysis. 
4.2.9. Statistical analysis 
Data were expressed as mean ± standard deviation. All the analysis were performed in 
triplicate.The data were analyzed by ANOVA, and the mean values were compared by Tukey 
test (α = 0.05), using XLStat statistical software (Addinsoft, New York, NY). The Pearson 
correlation coefficient was used for the bivariate correlation analysis between variables (α = 
0.05). Exploratory Principal Component Analysis (PCA) of the normalized variables was 
performed using XLStat statistical software (Addinsoft, New York, NY). 
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4.3. Results  
4.3.1. Physico-chemical characteristics of MS and DF products 
Table 4.2. shows the main physico-chemical characteristics of the newly developed MS and 8 
commercial products. The mean amount of TDF in powdered MS was about 13.1 % and was 
lower than that (71.7%) found in commercial DF products ranging from 19.1 % of oat bran up 
to 97.0 % of bamboo DF (mainly IDF). Barley β-glucans concentrate possessed the highest 
amount of SDF followed by citrus DF (17.1 g/100g of sample) and carrot DF (15.9 g/100g of 
sample) whose SDF accounted for 19.0% and 19.3% of TDF, respectively. Significant 
differences between wheat bran and oat bran for relative content of TDF and IDF, were found. 
Potato DF showed the highest values of WHC and OHC, whereas the powdered MS 
possessed the lowest values. Citrus DF and carrot DF also showed high WHC values, the one 
of carrot being higher than that of citrus DF. Bamboo DF possessed a low WHC, but a quite 
high  OHC, after potato DF and barley β-glucans. As expected, barley β-glucans concentrate 
possessed the highest water solubility, followed by wheat bran and powdered PPe-MS, 
whereas bamboo DF was at the bottom of the ranking list. Positive correlations between the 
amount of TDF and the WHC (r = 0.749; p = 0.005) and OHC (r = 0.648; p = 0.023), and 
between the amount of SDF and the water solubility (r = 0.908; p < 0.0001) were found. 
PPe-MS showed the highest TAC (5798.7 ± 365.6 µmol TE/100g) followed by OLe-MS 
(993.4 ± 25.9 µmol TE/100 g) and wheat bran (499.1 ± 5.6 µmol TE/100 g). Conversely, 
bamboo DF (12.8 ± 3.3 µmol TE/100 g ) citrus DF (35.4 ± 4.0 µmol TE/100 g) and carrot DF 
(69.4 ± 7.5 µmol TE/100 g) possessed the lowest TAC values 
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Table 4.2. Physico-chemical characteristics of the powdered MS and commercial DF concentrates. Values are expressed as mean ± SD. Values followed by the same letter 
within the same column are not significantly different (p > 0.05) according to Tukey’s Test. 
Products 
IDF 
(g/100 g) 
SDF 
(g/100 g) 
TDF 
(g/100 g) 
IDF/SDF 
 
WHC 
(mL/g) 
OHC 
(mL/g) 
Solubility 
(%) 
TAC 
(µmol TE/100 g) 
Oat bran 15.8 ± 1.3f 3.3 ± 0.4d,e 19.1 ± 0.9h 4.8 2.2 ± 0.4f 1.7 ± 0.2c,d 18.6 ± 0.3c,d 155.6 ± 7.0d,e 
Wheat bran 43.8 ± 0.8e 3.0 ± 0.1d,e 46.8 ± 0.9g 14.8 5.1 ± 0.3d 3.1 ± 0.2b 28.5 ± 0.6b 499.1 ± 5.6c 
Potato DF 65.6 ± 2.4d 8.6 ± 1.7c 74.2 ± 0.7f 7.6 11.5 ± 0.7 a 6.3 ± 0.3a 15.2 ± 2.3d,e 174.2 ± 11.8d,e 
Citrus DF 72.8 ± 1.7c 17.1 ± 2.0 b 89.9 ± 0.3b 4.3 8.3 ± 0.2b 2.1 ± 0.2c 15.2 ± 0.8d,e 35.4 ± 4.0e 
Bamboo DF 95.4 ± 0.1a 1.6 ± 0.2d,e 97.0 ± 0.1a 58.7 3.5 ± 0.3e 3.3 ± 0.1b 6.0 ± 1.7f 12.8 ± 3.3e 
Pea cortical 
DF 
82.1 ± 0.6b 4.8 ± 0.2c,d 87.1 ± 0.3c 17.3 5.2 ± 0.1d 1.5 ± 0.1d 11.4 ± 0.3e 98.2 ± 6.6e 
Carrot DF 66.5 ± 1.6d 15.9 ± 1.9b 82.4 ± 0.3d 4.2 8.4 ± 0.3b 3.2 ± 0.2b 15.7 ± 1.2d 69.4 ± 7.5e 
Barley β-
glucans 
1.6 ± 0.8g 75.5 ± 0.8a 77.1 ± 1.6e 0.02 7.0 ± 0.7c 3.5 ± 0.1b 77.4 ± 2.9a 80.3 ± 3.5e 
PPe-MS 12.4 ± 0.4f 1.7 ± 0.5d,e 14.1 ± 0.1i 7.4 2.2 ± 0.1f 0.7 ± 0.1e 21.3 ± 0.9c 5798.7 ± 365.6a 
ALe-MS 11.9 ± 0.1f 0.6 ± 0.1e 12.5 ± 0.2i 21.5 2.4 ± 0.2f 0.7 ± 0.1e 18.6 ± 0.7c,d 329.1 ± 11.1c,d 
OLe-MS 12.1 ± 0.1f 0.9 ± 0.1e 13.0 ± 0.2 i 13.7 2.2 ± 0.1f 0.7 ± 0.1e 16.1 ± 1.8d 993.4 ± 25.9b 
Control-MS 12.2 ± 0.5f 0.5 ± 0.1e 12.7 ± 0.6 i 24.0 2.2 ± 0.1f 0.7 ± 0.1e 16.2 ± 0.6d n.a. 
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4.3.2 Free and bound PPs in MS 
Tables 4.3., 4.4. and 4.5. report the main PPs present in powdered PPe-MS, Ole-MS and 
ALe-MS, respectively. The most abundant PPs were ellagitannins (ETs), mainly including 
punicalin and punicalagin, EA and its derivatives, in PPe-MS, secoiridoids and phenolic acids 
in OLe-MS and flavonoids and phenolic acids in ALe-MS. The total amount of PPs was 
higher in OLe-MS, followed by PPe-MS and ALe-MS. PPs were not detected in control-MS. 
In all the MS, PPs were mainly found in the free form.  
Table 4.3. PPs in PPe-MS. The values were expressed as mean ± SD. ETs were expressed as µg equivalents of punicalagin. 
Ellagic acid derivatives were expressed as µg equivalents of EA. Total PPs were expressed as the sum of µg equivalent of 
punicalagin + µg equivalent of EA + µg of GA. 
Compound Free 
(µg/g DM) 
Bound 
(µg/g DM) 
Total 
(µg/g DM) 
Punicalin 5708.0 ± 335.0 3.8 ± 1.4 5711.8 ± 334.2 
Punicalagin 1396.8 ± 72.2 n.d. 1397.3 ± 72.2 
Causarinin 131.6 ± 6.9 n.d. 131.6 ± 6.9 
Galloyl-HHDP-hexoside 1249.8 ± 117.7 23.6 ± 19.2 1273.5 ± 98.5 
Granatin B 651.8 ± 65.8 n.d. 651.8 ± 65.8 
ETs 9138.1 ± 482.1 27.9 ± 20.5 9166.0 ± 470.8 
Ellagic acid hexoside 142.7 ± 13.5 n.d. 142.7 ± 13.5 
Ellagic acid pentoside 14.2 ± 3.1 n.d. 14.2 ± 3.1 
Ellagic acid deoxyhexoside 65.6 ± 7.1 n.d. 65.6 ± 7.1 
Ellagic acid 740.4 ± 19.0 13.8 ± 2.1 754.2 ± 17.0 
EAs 963.0 ± 38.5 13.8 ± 2.1 976.8 ± 37.1 
Gallic acid 619.5 ± 83.5 12.4 ± 7.7 631.9 ± 90.5 
Total PPs 10720.6 ± 426.1 54.1 ± 29.0 10774.7 ± 414.0 
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Table 4.4. PPs in OLe-MS. The values were expressed as mean ± SD. Apigenin and luteolin glycosides were expressed as 
µg equivalents of luteolin-4-O-glucoside. Secoiridoids were expressed as µg equivalents of oleuropein. Total PPs were 
expressed as the sum of µg equivalent of phenolic acids + µg equivalent of flavonoids + µg equivalent of secoiridoids + µg 
equivalent of Hydroxytyrosol. 
Compound Free 
(µg/g DM) 
Bound 
(µg/g DM) 
Total 
(µg/g DM) 
Protocatechuic acid 3.2 ± 0.1 0.1 ± 0.0 3.3 ± 0.1 
Verbascoside 80.1 ± 1.7 n.d. 80.1 ± 1.7 
p-coumaric acid n.d. 6.6 ± 1.7 6.6 ± 1.7 
Ferulic acid 7.0 ± 0.7 13.4 ± 5.8 20.4 ± 6.4 
Phenolic acids 90.3 ± 1.8 20.1 ± 7.5 110.4 ± 9.0 
Luteolin rutinoside 317.1 ± 13.8 4.8 ± 0.4 321.9 ± 14.0 
Rutin 65.1 ± 1.9 n.d. 65.1 ± 1.9 
Apigenin rutinoside 242.1 ± 43.0 5.0 ± 1.4 247.1 ± 41.9 
Luteolin glucoside 3443.7 ± 136.7 90.2 ± 13.7 3533.9 ± 123.2 
Apigenin glucoside 82.6 ± 0.8 9.6 ± 2.3 92.2 ± 1.7 
Flavonoids 4150.5 ± 188.0 109.6 ± 17.0 4260.1 ± 171.0 
3,4-DHPEA-AC 3372.6 ± 398.6 45.2 ± 2.5 3417.8 ± 399.2 
Elenolic acid 6870.6 ± 277.0 n.d. 6870.6 ± 277.0 
p-HPEA-EA 1988.4 ± 107.7 0.5 ± 0.3 1988.9 ± 108.0 
Oleuropein 38132.3 ± 871.2 n.d. 38132.3 ± 871.2 
Ligstroside 194.0 ± 39.6 n.d. 194.0 ± 39.6 
Methyl-DHPEA-EA 793.4 ± 28.2 2.4 ± 0.8 795.1 ± 28.4 
Secoiridoids 51351.4 ± 1097.2 47.3 ± 3.4 51398.7 ± 1100.0 
Hydroxytyrosol 48.3 ± 1.8 n.d. 48.3 ± 1.8 
Total 55640.5 ± 1284.2 177.1 ± 8.9 55817.5 ± 1275.4 
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Table 4.5. PPs in ALe-MS. The values were expressed as mean ± SD.  Luteolin and apigenin glycosides were expressed as 
µg equivalents of luteolin and apigenin, respectively. Caffeoylquinic acid isomers were expressed as µg equivalents of 
chlorogenic acid. Dicaffeoylquinic acid isomers were expressed as µg equivalents of cynarin. Total PPs were expressed as 
the sum of µg equivalent of phenolic acids + µg equivalent of flavonoids. 
Compound Free 
(µg/g DM) 
Bound 
(µg/g DM) 
Total 
(µg/g DM) 
Caffeoylquinic acid isomers 232.2 ± 51.6 0.14 ± 0.07 232.2 ± 51.6 
Caffeic acid 0.5 ± 0.1 14.1 ± 0.3 14.6 ± 0.4 
Dicaffeoylquinic acid 
isomers 
280.6 ± 61.1 1.6 ± 0.6 282.2 ± 60.4 
Phenolic acids 513.3 ± 112.1 15.8 ± 0.4 529.1 ± 111.8 
Luteolin 7-O- rutinoside 0.8 ± 0.2 0.2 ± 0.1 1.0 ± 0.2 
Luteolin 7-O-glucoside 136.6 ± 18.5 49.1 ± 8.3 185.7 ± 10.2 
Luteolin 7-O-glucuronide 6.0 ± 0.9 2.4 ± 0.7 8.4 ± 0.2 
Apigenin 7-O-glucoside 1.6 ± 0.3 3.0 ± 0.3 4.6 ± 0.2 
Luteolin 7-O-malonyl-
glucoside 
89.9 ± 11.6 n.d. 89.9 ± 11.6 
Apigenin 7-O-glucuronide n.d. 0.5 ± 0.1 0.5 ± 0.1 
Luteolin 5.6 ± 0.8 0.8 ± 0.1 6.4 ± 0.9 
Apigenin 0.3 ± 0.2 0.1 ± 0.01 0.4 ± 0.2 
Flavonoids 240.7 ± 32.5 56.2 ± 9.0 296.8 ± 23.5 
Cynaropycrin 251.1 ± 25.7 n.d. 251.1 ± 25.7 
Total PPs 754.0 ± 143.3 72.0 ± 9.3 826.0 ± 134.1 
4.3.3. Free and bound antioxidant capacity of MS and DF products 
Figure 4.1. shows the free-AC and bound-AC of all the products. 
Among the commercial DF products, potato DF showed the highest value of free-AC (148.5 ± 
9.8 µmol TE/100g), followed by pea cortical DF (80.4 ± 7.7 µmol TE/100g) and barley β-
glucans concentrate (59.8 ± 2.6  µmol TE/100g). Conversely, bamboo DF possessed the 
lowest values of free-AC and bound-AC. Concerning cereal brans, as expected wheat bran 
free-AC (218.2 ± 7.6 µmol TE/100g) was more than double of that of oat bran (100.3 ± 8.3 
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µmol TE/100g) and the bound-AC of wheat bran was more than 5 folds higher of oat bran 
bound-AC (280.9 ± 5.1 vs 55.2 ± 1.6 µmol TE/100g, respectively). Interestingly, powdered 
PPe-MS showed a bound-AC (242.3 ± 28.9 µmol TE/100g) comparable to wheat bran and 4.4 
folds higher than oat bran bound-AC (55.2 ± 1.6 µmol TE/100g). Citrus DF, wheat bran and 
carrot DF were the products with the highest percentage of bound-AC accounting for 62%, 
56% and 44% of the respective TAC (sum of free-AC and buond-AC).  
Figure 4.1. Free-AC and Bound-AC calculated for the products. Resultes were expressed as µmol of Trolox 
Equivalents (TE)/100g of product. Different lower case letter (for bound-AC values) and different upper case 
letter (for free-AC values) indicated statistically significant differences (p < 0.05) among the samples, according 
to Tukey's Test. 
4.3.4 Potential impact of newly developed MS 
Figure 4.2. reports the result of an explorative principal component analysis (PCA) including 
all the data obtained. The first two principal components (axis PC1 and PC2) explained 
approximately 65% of the total data variance including variance linked to each variable, the 
one common among variables, and error variance. The left box in the figure 4.2. shows the 
relationship between the analysed products and the variables (loadings plot) while the right 
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box report the PCA scores plot. This analysis revealed a defined clustering behavior except 
for one sample in the first quarter that was considered an outlier (β-glucans concentrate). Data 
showed that the MS were clustered together with wheat bran and oat bran in the left part of 
the scores plot graph. Specifically, PPe-MS, wheat bran and oat bran were located in the same 
quarter, where the value of PC1 was negative and the value of PC2 was positive. Conversely, 
excluding barley β-glucans, the other products were grouped in the right part of the scores 
plot graph. Citrus DF, pea cortical DF and bamboo DF were placed in the second quarter 
where PC1 was positive and PC2 was negative. Carrot DF and potato DF were located in the 
first quarter (positive values for PC1 and PC2). Barley β-glucans concentrate was considered 
an outlier due to its high percentage of SDF and to the high water solubility, which 
contributed for the 29.3% and 34.0% of the PC2, respectively. 
Figure 4.2. Exploratory Principal Component Analysis (PCA). 
4.3.5. In vitro gastrointestinal digestion of PPe-MS 
Figure 4.3. shows the concentration of PPe-MS PPs released at each step of the 
gastrointestinal in vitro digestion. Punicalagin, punicalin and other ETs from PPe-MS were 
mainly released in the simulated oral phase (SOP). Only a small residual fraction of punicalin 
(40.9 ± 7.5 µg of punicalagin equivalent/g of dry MS) was detected in the simulated intestinal 
phase (SIP). Conversely, EA and EA-derivatives were mainly released in the simulated 
gastric phase (SGP) and in the SIP. GA was not detected in the SOP extract but was mainly 
released in the SGP (141.5 ± 4.2 µg /g of dry MS) and in the SIP (39.5 ± 1.7 µg/g of dry MS). 
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The pellets resulting from the SIP were hydrolyzed in order to analyze the amount of residual 
PPs entrapped in the matrix after the gastrointestinal in vitro digestion. Interestingly, data 
reported in Table 4.6. showed that small residual fractions of EA (11.2 ± 0.02 µg/g of dry 
MS), punicalin (4.1 ± 0.1 µg of punicalagin equivalent/g of dry MS) and punicalagin (1.2 ± 
0.1 µg /g of dry MS), were released after the alkaline hydrolysis of the residual pellets thus 
demonstrating that a residual fraction of PPs from PPe-MS may be potentially released in the 
colon. PPs were not found in the digestive extract of control-MS. 
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Figure 4.3. PPs released during in vitro gastrointestinal digestion of PPe-MS. Punicalin, Causarinin, Granatin B and Galloyl-HHDP-hexoside were reported as µg of 
punicalagin equivalent. EA derivatives were reported as µg of EA equivalents. 
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Table 4.6. PPs released after hydrolysis on the pellets resulting by the simulated intestinal phase of MS in vitro 
digestion.  
Compound 
Buond PPs released  after in 
vitro digestion 
(µg/g dry MS) 
Punicalin 4.1 ± 0.1 
Punicalagin 1.2 ± 0.1 
Causarinin n.d. 
Galloyl-HHDP-hexoside 0.8 ± 0.4 
Granatin B n.d. 
ETs 6.0 ± 0.7 
Ellagic acid hexoside n.d. 
Ellagic acid pentoside n.d. 
Ellagic acid deoxyhexoside n.d. 
Ellagic acid 11.2 ± 0.02 
EAs 11.2 ± 0.02 
Gallic acid n.d. 
Total PPs 17.2 ± 0.7 
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4.4. Discussion 
In this study for the first time three types of antioxidant DF-rich ingredients were designed 
and developed. The new ingredients were MS based on the combined inclusion of native corn 
starch and PPs in a calcium-alginate matrix. The basic structure of the new MS, i.e. corn 
starch entrapped in the spherical alginate matrix, was previously demonstrated to limit the 
extent of starch digestion in the small intestine thus allowing its fermentation in the colon.39,40 
Moreover, starch-based MS were able to decrease postprandial blood glucose 60 min after 
ingestion.60 
Data of the present study demonstrated that the inclusion of PPs-extracts in MS formulation 
resulted in new starch-alginate based MS that could be considered an antioxidant DF. The 
three types of powdered MS showed higher free TAC than commercial DF, and the bound-
TAC of PPe-MS was even comparable to that of wheat bran and 4.4 folds higher than oat-
bran. 
This finding is very interesting because wheat bran is one of the best natural source of bound-
PPs, mainly including ferulic acid, and it is well-recognized for its health properties along the 
GiT.26,28,62 Similarly, oat bran possesses PPs bound to IDF and that can be released after a 
chemical or enzymatic hydrolysis, as well as by microbial fermentation in the colon.26,63-65 
Many epidemiological studies have demonstrated that regular consumption of whole grains 
and whole grain products is associated with reduced risks of various types of non-
communicable chronic diseases such as cardiovascular diseases, type 2 diabetes, and some 
types of cancer, mainly including colon cancer.66 The health benefits of whole grains have 
been attributed in part to their phytochemicals, most of which are covalently bound to the IDF 
portion of the bran fraction.67,68 Moreover, the consumption of whole grain products, mainly 
including wheat bran and oat bran, was associated with beneficial modifications of the colonic 
microbial community, including an enhanced growth of probiotic bacteria, as well as to 
improvements of antioxidant and inflammatory status, both in animals and in humans.28,69-73 
Although OLe-MS possessed a higher amount of total PPs than PPe-MS, the latter showed a 
TAC that was 6 and 18 folds higher than the TAC of OLe-MS and Ale-MS, respectively. 
These findings can be explained by considering the huge variability of the antioxidant 
capacity associated to various PPs.74,75 Phenolic acids, mainly including ferulic acid, are the 
most abundant phenolic compounds covalently associated to the IDF of wheat bran and oat 
bran and can be released after an alkaline hydrolysis.65,76 Secoiridoids, mainly including 
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oleuropein, were the most abundant compounds detected in OLe-MS. ETs, EA and GA were 
the main PPs detected in PPe-MS. EA and GA are recognized as more effective antioxidant 
compounds and active inhibitors of free radicals compared to ferulic acid and PPs detected in 
OLe-MS.77,78 On the other hand, punicalagin is one of the strongest natural antioxidant 
compounds, exhibiting an antioxidant capacity that is 16, 7, 16  and 13 folds higher than the 
antioxidant capacity measured for EA, GA, protocatechuic acid and p-coumaric acid, 
respectively.79 
On the basis of their great antioxidant capacity, the potential efficacy of PPe-MS to deliver 
PPs along the GiT was tested by applying an in vitro gastrointestinal digestion. In order to 
simulate the utilization of PPe-MS as functional ingredient in foods, they were cooked before 
the analysis. As it could be expected, data showed thata fraction of total PPs was partially lost 
during the cooking process. However, it was also demonstrated that the release of residual 
ETs decreased from the SOP to the SIP whereas GA, EA and EA-derivatives had an opposite 
trend. This finding was in accordance with previous evidence showing that ETs can be 
hydrolyzed under physiological conditions, thus mainly releasing GA, EA and EA glycosidic 
derivatives in the SIP.80 Moreover, accordingly with in vivo evidence demonstrating that only 
a part of EA is absorbed in the intestinal lumen while the other part reaches the colon, the 
alkaline hydrolisis of the final pellet resulting from the SIP showed that residual fractions of 
EA and ETs could potentially reach the colon. So, it could be speculated that the consumption 
of the PPe-MS may lead to a release of EA and ETs to the colon, consequently creating a 
reducing environment in the gut, as well as promoting the microbial transformation of these 
PPs into the more adsorbable bioactive urolithins.80 Further studies are warrented to test these 
hypothesys in vivo. 
Another important finding of this study regarded the positioning of the new MS in the 
scenario of the commercially available DF as regards the content of TDF, WHC, OHC, other 
than TAC and Free-TAC. In this respect exploratory PCA data indicated that the three MS 
could be engrouped with oat bran and wheat bran in the left part of the scores plot graph, 
whereas the others DF-concentrate, (excluding β-glucans that was considered an outsider) 
constituted a separate group in the right part of the scores plot graph graph (see Figure 4.2.). 
Specifically in the left part of the graph the products with higher antioxidant activity and 
lower amount of TDF were reported, conversely the other products were grouped in the right 
part of the graph. Furthermore, observing the loadings plot graph it is possible to see that, as 
expected OHC and WHC are parameters strictly related to the amount of TDF.    
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That the average content of TDF in MS, wheat bran and oat bran was lower and that, 
consequently also the WHC and OHC could be lower, than those of the 6 commercial DF-
concentrates, was an expected finding. However, the TAC of MS, wheat bran and oat bran 
was higher compared to the TAC measured for the 6 commercially available DF-concentrates. 
This cluster behavior could be explained by considering both the individual characteristics of 
the productsas well as the processing conditions that commercial DF could undergo in order 
to optimize the technological properties. It is well known that chemical, mechanical, thermal 
and enzymatic processing can modify the properties of DF, mainly including WHC, OHC, 
solubility and TAC.81 
IDF was the predominant fraction of TDF in MS and it was mainly constituted by calcium-
alginate, an insoluble salt of alginic acid. Alginic acid is a linear indigestible anionic 
polysaccharide extracted from brown seaweed, constituted by β-(1,4)-mannuronic acid and α-
(1,4)-guluronic acid and is depolymerized by the action of specific alginate lyases.82,83 
According to Park and Jhon, (2009), also bamboo TDF was mainly constituted by IDF 
(98.3%) whereas barley β-glucans concentrate was mainly constituted by SDF (97.9%).84 
That the content of TDF and IDF was higher in wheat bran compared to oat bran was also in 
line with the literature.26 
On the other hand MS possessed a low water-solubility, WHC and OHC compared to the 
other DF.The WHC and the OHC indicate the amount of water and oil retained by a certain 
weight of product under specific conditions.81 These properties, together with the water 
solubility, have both technological and physiological relevance. DF with a high WHC can be 
useful to avoid the synaeresis and modify the viscosity and texture of food formulations.85,86 
From a physiological perspective it may induce a prolonged mastication and increase faecal 
bulk volume, thus potentially influencing satiation and appetite.87-89 DF possessing a high 
OHC is useful to stabilize food emulsions, as well as to decrease fat digestion and absorption 
along the GiT.81,85,90 
As regards the water solubility, a highly water-soluble DF can affect the viscosity of foods 
and from the pysiological point of view, may influence nutrients absorption in the GiT.81 
Those functions are well recognized in the literature for barley β-glucans concentrate, 
showing the highest water-solubility among the tested products.91, 92 
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4.5. Conclusions  
In this study three types of antioxidant DF, constituted by PPs extracted from three common 
plant by-products and included in starch-alginate based MS, were developed. The new 
ingredients showed a TAC that could act both in the food matrix and along the GiT, as 
demonstrated in vitro for the PPe-MS. In the actual scenario of commercially available DF, 
data showed that the new antioxidant MS were very similar to wheat bran and oat bran for the 
main physical-chemical properties other than for the antioxidant capacity. This comparison let 
us hypothesize that these ingredients are very promising for both technological and 
physiological pespective. Further studies are warranted to assess the impact of the MS in food 
formulation and to demonstrate in vivo the antioxidant efficacy and the impact on health. 
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4.6 Abbreviations 
ALe: Artichoke leaves; 
ALe-MS: ALe-Microspheres; 
DF: Dietary fiber; 
EA: Ellagic acid; 
EAs: Ellagic acid derivatives; 
ETs: Ellagitannins; 
GA: Gallic acid; 
GiT: Gastrointestinal tract;; 
IDF: Insoluble dietary fiber; 
MS: Microspheres; 
NCCDs: Non communicable chronic diseases; 
OHC: Oil holding capacity; 
OLe: Olive leaves; 
OLE-MS: OLe-Microspheres 
PCA: Principal component analysis; 
PPe: Pomegranate peels; 
PPe-MS: PPe-Microspheres; 
PPs: Polyphenols; 
SCFAs: Short-chain fatty acids; 
SDF: Soluble dietary fiber; 
SGP: Simulated gastric phase; 
SIP: Simulated intestinal phase; 
SOP: Simulated oral phase; 
TAC: Total antioxidant capacity; 
TDF: Total dietary fiber; 
TE: Trolox equivalents; 
WHC: Water-holding capacity; 
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5.1 Summary, conclusions and future perspectives 
In the last decades, a growing number of functional foods promising a huge variety of health 
properties beyond their nutritional aspects, was developed and entered on the market.1  
Both food processing and food composition may affect the food quality and the behavior of 
nutrients and non-nutrients in the gastrointestinal tract (GiT).2-8 On the other hand, the 
environmental conditions (i.e. pH changes, time of transit, permeability of the gastrointestinal 
mucosa, presence of salts, mucine, enzymes and emulsifying molecules in the intestinal 
lumen) associated to the physiological processes taking place along the GiT (i.e. the 
gastrointestinal motility, activities of digestive enzymes and host microbiota) are also key 
factors influencing the bioaccessibility and bioavailability of macronutrients, micronutrients 
and bioactive non-nutritional compounds in foods.8-10 
So the lacking information about the influence of food processing and matrix on the bioactive 
compounds together with the fate and the potential functional properties along the GiT, may 
be an important cause of costly late-stage failures in functional foods development process. 
Therefore, it has become widely appreciated that those parameters should be elucidated as 
early as possible.11, 12 
Human trials are necessary to evaluate the physiological responses and the effects following 
the consumption of specific bioactive compounds. However in vitro assays are a useful tool to 
elucidate a specific mechanism underlying a physiological response, or to foresee the effects 
of food processing and food matrix on the functionality and bioaccessibility of food 
bioactives in the GiT.13 
In vitro digestion models, coupled to chemical analysis and biochemical assays allow us to 
study the potential fate of targeted food components along the GiT and the potential 
mechanisms behind modulation of oxidative and inflammatory processes as well as nutrient 
metabolism.14-19 
This approach was used during the implementation of this work that was described in 5 
chapters and whose main conclusions are summarized as follows. 
In Chapter 1 a brief introduction on the worldwide spread of obesity and an overview on the 
role of bioactive compounds, mainly including polyphenols (PPs) and dietary fiber (DF), to 
counteract weight gain and metabolic syndrome was presented. Furthermore, the concept of 
plant foods by-products as rich sources of bioactive compounds was introduced. 
Chapter 5 Summary, conclusions and future perspectives 
130 
 
In Chapter 2 pomegranate peels (PPe) were proposed as functional ingredient for the 
development of functional cookies. The findings supported the use of PPe at a dose of 7.5% 
by weight in bakery food products, as a functional ingredient to counteract oxidative stress 
along the GiT. The potential antioxidant protection may involve all the organs of the GiT due 
to the release of PPs from PPe along all the digestive system. Moreover, it was demonstrated 
that the baking process increased the amount of ellagic acid in the PPe-enriched cookies due 
to chemical degradation of ellagitannins, thus allowing its increased release in the duodenal 
and colon phase compared to the raw PPe. Together with a high antioxidant potential, the mix 
of PPs solubilized in the simulated duodenal phase also acted as strong inhibitors of α-
glucosidase, thus possibly influencing in a positive manner the glucose metabolism in vivo.  
In Chapter 3 artichoke stems from "Tondo di Paestum" were selected among artichoke by-
products and used at 3%, 6% and 9% in the formulation of new types of bread. The potential 
bioaccessibility of PPs and of the bitter sesquiterpene lactone cynaropicrin from the breads as 
well as the overall total antioxidant capacity (TAC) and potential ability to modulate α-
glucosidase activity in the GiT were assessed. Data showed that the potential release of PPs 
and cynaropicrin as well as the antioxidant activity and α-glucosidase activity in the small 
intestine correlated with the amount of ASP added to the bread recipe. Interestingly, a part of 
these bioactive compounds were potentially released in the colon step after a biochemical 
conversion induced by enzymes of microbial origin, thus suggesting an effect of the new 
foods that may be mediated by the intestinal microbiota in vivo. Finally, it was demonstrated 
that PPs from artichoke stem were less active against α-glucosidase compared to PPs from 
PPe.  
In Chapter 4, three PPs-rich extracts were obtained from PPe, olive leaves (OLe) and 
artichoke leaves (ALe), and were used as a functional filling for the development of new 
starch-alginate based microspheres. The physico-chemical properties of the new ingredients 
were compared to those of 6 commercially available DF concentrates, as well as to wheat 
bran and oat bran. PPe-microspheres (PPe-MS) were submitted to an in vitro simulated 
gastrointestinal digestion in order to evaluate their potential efficacy to deliver PPs and to 
exert antioxidant activity along the GiT. The new ingredients exhibited antioxidant activity 
inside the food and along the GiT, as demonstrated in vitro for the PPe-MS. In the actual 
scenario of commercially available DF, data showed that the new antioxidant MS were very 
similar to wheat bran and oat bran for the main physical-chemical properties other than for the 
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antioxidant capacity. This comparison let us hypothesize that these ingredients were very 
promising for both technological and physiological perspective.  
In Chapter 5 the concluding remarks and future perspectives of the work were reported.  
For a general conclusion it is important to stress that due to the main limitation of in vitro 
model systems to fully mimic the overall processes occurring in vivo (such as absorption, 
hormonal and nervous responses, feedback mechanisms, mucosal cell activity, complexity of 
peristaltic movements, and involvement of the local immune system), human trials are needed 
to confirm findings from in vitro studies here presented and for the final validation of the new 
foods/ingredients designed and tested in this work. 
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